Page last updated: 2024-11-02

oxonic acid and Peritoneal Carcinomatosis

oxonic acid has been researched along with Peritoneal Carcinomatosis in 215 studies

Oxonic Acid: Antagonist of urate oxidase.

Research Excerpts

ExcerptRelevanceReference
"The aim of this study was to determine the feasibility of S-1 plus oxaliplatin (SOX) or capecitabine plus oxaliplatin (XELOX) as first-line therapy for patients with initially unresectable metastases from colorectal cancer."7.79Feasibility study of oxaliplatin with oral S-1 or capecitabine as first-line therapy for patients with metastases from colorectal cancer. ( Akiba, T; Enomoto, H; Kawahara, H; Toyama, Y; Watanabe, K; Yanaga, K, 2013)
" Here, we report the case of a patient with systemic sclerosis who developed severe digital ischemia during combination gemcitabine/S-1 chemotherapy for pancreatic cancer."7.77A case of progressive digital ischemia after early withdrawal of gemcitabine and S-1 in a patient with systemic sclerosis. ( Chiba, T; Ishikawa, S; Kanai, M; Kawaguchi, Y; Masui, T; Matsumoto, S; Mimori, T; Mori, Y; Nishimura, T; Yanagihara, K; Zaima, C, 2011)
"We report a patient with type 3 gastric cancer with peritoneal dissemination and hydronephrosis who was successfully treated with intraperitoneal infusion of paclitaxel and oral administration of S-1."7.74Intraperitoneal administration of paclitaxel and oral S-1 for a patient with peritoneal dissemination and hydronephrosis due to advanced gastric cancer. ( Miki, H; Nakahira, S; Nakata, K; Okada, K; Okamura, S; Sugimoto, K; Takatsuka, Y; Takiuchi, D; Tamura, S; Tomita, N, 2007)
"Paclitaxel was used as the first-line drug for treatment of a case with peritoneal recurrence of gastric cancer, accompanied by cancerous ascites."7.73[A case of paclitaxel-resistant cancerous ascites secondary to gastric carcinoma responding well to TS-1 therapy]. ( Hara, A; Iwamoto, S; Izumi, N; Tsunemi, S; Yamamoto, M, 2006)
"Paclitaxel (PTX) was administered via an IP access port implanted in the subcutaneous space."5.42Cell-free and concentrated ascites reinfusion therapy (CART) for management of massive malignant ascites in gastric cancer patients with peritoneal metastasis treated with intravenous and intraperitoneal paclitaxel with oral S-1. ( Emoto, S; Hanafusa, N; Ishigami, H; Ito, T; Kitayama, J; Watanabe, T; Yamaguchi, H, 2015)
"Peritoneal metastasis of gastric cancer has extremely poor clinical outcomes."5.40Salvage gastrectomy after intravenous and intraperitoneal paclitaxel (PTX) administration with oral S-1 for peritoneal dissemination of advanced gastric cancer with malignant ascites. ( Emoto, S; Ishigami, H; Kaisaki, S; Kitayama, J; Watanabe, T; Yamaguchi, H; Yamashita, H, 2014)
"We report two cases of advanced gastric cancer."5.38[Two cases of advanced gastric cancer with peritonitis carcinomatosa that showed disappearance of ascites and obtained a good quality of life by using DIF and paclitaxel]. ( Kodama, M; Mekata, E; Okumura, K; Shiogai, Y; Tan, T; Tani, S, 2012)
" Weekly intravenous and intraperitoneal PTX combined with S-1 was highly effective in gastric cancer with malignant ascites."5.36Weekly intravenous and intraperitoneal paclitaxel combined with S-1 for malignant ascites due to advanced gastric cancer. ( Hidemura, A; Ishigami, H; Kaisaki, S; Kamei, T; Kato, M; Kitayama, J; Miyato, H; Nagawa, H; Otani, K; Soma, D; Yamashita, H, 2010)
"After the 5th course, the stenosis of colon and ascites had disappeared in a barium enema and CT scan, respectively."5.32[A case of advanced type 4 gastric cancer with peritonitis dissemination, navel metastasis effectively treated with combined chemotherapy of biweekly paclitaxel (TXL) and TS-1]. ( Aikou, T; Arima, H; Hamada, N; Hokita, S; Ishigami, S; Maeda, S; Miyazono, F; Natsugoe, S; Takao, S; Takatori, H, 2003)
"The aim of this study was to determine the feasibility of S-1 plus oxaliplatin (SOX) or capecitabine plus oxaliplatin (XELOX) as first-line therapy for patients with initially unresectable metastases from colorectal cancer."3.79Feasibility study of oxaliplatin with oral S-1 or capecitabine as first-line therapy for patients with metastases from colorectal cancer. ( Akiba, T; Enomoto, H; Kawahara, H; Toyama, Y; Watanabe, K; Yanaga, K, 2013)
"A total of 123 patients with unresectable or recurrent gastric adenocarcinoma with peritoneal metastasis receiving intravenous and intraperitoneal paclitaxel combined with S-1 were retrospectively studied."3.78Role of intervention for biliary and gastric/intestinal obstruction in gastric cancer with peritoneal metastasis. ( Emoto, S; Hirano, K; Isayama, H; Ishigami, H; Kawakubo, K; Kitayama, J; Kogure, H; Koike, K; Nakai, Y; Sasahira, N; Sasaki, T; Tada, M; Yamaguchi, H; Yamamoto, N, 2012)
" Here, we report the case of a patient with systemic sclerosis who developed severe digital ischemia during combination gemcitabine/S-1 chemotherapy for pancreatic cancer."3.77A case of progressive digital ischemia after early withdrawal of gemcitabine and S-1 in a patient with systemic sclerosis. ( Chiba, T; Ishikawa, S; Kanai, M; Kawaguchi, Y; Masui, T; Matsumoto, S; Mimori, T; Mori, Y; Nishimura, T; Yanagihara, K; Zaima, C, 2011)
"We report a patient with type 3 gastric cancer with peritoneal dissemination and hydronephrosis who was successfully treated with intraperitoneal infusion of paclitaxel and oral administration of S-1."3.74Intraperitoneal administration of paclitaxel and oral S-1 for a patient with peritoneal dissemination and hydronephrosis due to advanced gastric cancer. ( Miki, H; Nakahira, S; Nakata, K; Okada, K; Okamura, S; Sugimoto, K; Takatsuka, Y; Takiuchi, D; Tamura, S; Tomita, N, 2007)
"Paclitaxel was used as the first-line drug for treatment of a case with peritoneal recurrence of gastric cancer, accompanied by cancerous ascites."3.73[A case of paclitaxel-resistant cancerous ascites secondary to gastric carcinoma responding well to TS-1 therapy]. ( Hara, A; Iwamoto, S; Izumi, N; Tsunemi, S; Yamamoto, M, 2006)
" The mean values of 5-fluorouracil (5-FU) concentrations in ascites of the S-1 group at 1-4 h were 414-580 ng/ml (n=5), and those of FT group were 70-87 ng/ml (n=5), with significant differences between the two groups at each observation time."3.72Dihydropyrimidine dehydrogenase inhibitory fluoropyrimidine S-1 may be effective against peritoneal dissemination in gastric cancer. ( Hirakawa, K; Nakata, B; Yamagata, S, 2004)
"The prognosis of stage III gastric cancer (GC) is not satisfying and the specific chemotherapy regimens for GC of stage IIIC based on the 8th edition of the UICC/AJCC TNM staging system are still inconclusive."3.11Addition of sintilimab to nanoparticle albumin-bound paclitaxel and S-1 as adjuvant therapy in stage IIIC gastric cancer. ( Feng, T; Li, C; Mei, Y; Shi, M; Yan, C; Yan, M; Yuan, H; Zhang, J; Zhu, Z, 2022)
"Six patients with gastric cancer with peritoneal metastasis were enrolled."3.01Phase 1 Study of Combined Chemotherapy of Nab-Paclitaxel, S-1, and Oxaliplatin for Gastric Cancer with Peritoneal Metastasis (NSOX Study). ( Hayata, K; Katsuda, M; Kitadani, J; Nakamori, M; Nakamura, M; Ojima, T; Yamaue, H, 2021)
" Recently, superiority of IP administration of paclitaxel (PTX) combined with S-1 and intravenous PTX over conventional systemic chemotherapy was suggested in a phase III study, although the difference in overall survival did not reach statistical significance in the primary analysis."2.94Phase I Study of Intraperitoneal Administration of Paclitaxel Combined with S-1 Plus Cisplatin for Gastric Cancer with Peritoneal Metastasis. ( Ishigami, H; Kanda, M; Kitayama, J; Kobayashi, D; Kodera, Y; Tanaka, C; Yamaguchi, H, 2020)
"Gemcitabine was administered at a dose of 1000 mg/m2 by 30 min infusion on days 1, S-1 40 mg/m2 orally twice daily and LV 25 mg orally twice daily on days 1 to 7 every 2 weeks."2.90A phase II trial of gemcitabine, S-1 and LV combination (GSL) therapy in patients with advanced pancreatic cancer. ( Hakuta, R; Hamada, T; Ijichi, H; Isayama, H; Ishigaki, K; Kishikawa, T; Kogure, H; Koike, K; Matsubara, S; Mizuno, S; Nakai, Y; Saito, K; Saito, T; Sasaki, T; Tada, M; Takahara, N; Takeda, T; Tateishi, K; Uchino, R; Yamamoto, N, 2019)
" Major grade 3/4 adverse events during NAC were neutropenia (29."2.90Randomized phase III trial of gastrectomy with or without neoadjuvant S-1 plus cisplatin for type 4 or large type 3 gastric cancer, the short-term safety and surgical results: Japan Clinical Oncology Group Study (JCOG0501). ( Boku, N; Hirao, M; Ito, Y; Iwasaki, Y; Kaji, M; Katai, H; Katayama, H; Kimura, Y; Kurita, A; Mizusawa, J; Nakamura, K; Sano, T; Sasako, M; Takagi, M; Terashima, M; Yamada, M; Yoshikawa, T, 2019)
"Patients diagnosed with CY+ advanced gastric cancer and treated with S-1-based therapy were enrolled."2.84Retrospective comparison of S-1 plus cisplatin versus S-1 monotherapy for the treatment of advanced gastric cancer patients with positive peritoneal cytology but without gross peritoneal metastasis. ( Chin, K; Hiroki, O; Ichimura, T; Matsushima, T; Nakayama, I; Ogura, M; Ozaka, M; Shinozaki, E; Suenaga, M; Takahari, D; Wakatsuki, T; Yamaguchi, K, 2017)
"Paclitaxel was administered i."2.84Multicenter Phase II Study of Intravenous and Intraperitoneal Paclitaxel With S-1 for Pancreatic Ductal Adenocarcinoma Patients With Peritoneal Metastasis. ( Fujii, T; Honda, G; Isayama, H; Ishigami, H; Kodera, Y; Kon, M; Kurata, M; Mizuma, M; Motoi, F; Satoi, S; Takahara, N; Unno, M; Yamada, S; Yamamoto, T; Yanagimoto, H, 2017)
" Grade 3 or worse adverse events were less frequent in the elderly group receiving SOX than in the elderly group receiving CS except for the low incidence of sensory neuropathy (5."2.82Efficacy and safety of S-1 and oxaliplatin combination therapy in elderly patients with advanced gastric cancer. ( Amagai, K; Bando, H; Chin, K; Fujii, H; Gotoh, M; Hamada, C; Hironaka, S; Hyodo, I; Imamura, H; Miwa, H; Nishikawa, K; Nishina, T; Niwa, Y; Shimada, K; Sugimoto, N; Tanabe, S; Tsuda, M; Tsuji, A; Yamada, Y; Yamaguchi, K; Yasui, H, 2016)
"Postoperative complications were identified in 18 patients and the overall morbidity rate was 26."2.79Low creatinine clearance is a risk factor for D2 gastrectomy after neoadjuvant chemotherapy. ( Aoyama, T; Cho, H; Hayashi, T; Ito, Y; Miyashita, Y; Morita, S; Nishikawa, K; Ogata, T; Sakamoto, J; Tanabe, K; Tsuburaya, A; Yoshikawa, T, 2014)
" This phase 2 study evaluated the benefits and tolerability of weekly intravenous and intraperitoneal paclitaxel (PTX) treatment combined with oral S-1 in patients with gastric cancer who had macroscopic peritoneal metastasis."2.78A phase 2 trial of intravenous and intraperitoneal paclitaxel combined with S-1 for treatment of gastric cancer with macroscopic peritoneal metastasis. ( Emoto, S; Ishigami, H; Kitayama, J; Watanabe, T; Yamaguchi, H; Yamashita, H, 2013)
"Peritoneal metastasis is treated more effectively by this regimen than other forms of metastases."2.78Combination of low-dose docetaxel and standard-dose S-1 for the treatment of advanced gastric cancer: efficacy, toxicity, and potential predictive factor. ( Chen, Y; Cui, Y; Feng, Y; Li, Q; Liu, T; Wang, Y; Yu, Y, 2013)
"S-1 in patients with advanced gastric cancer (AGC)."2.78Randomized phase II study comparing paclitaxel with S-1 vs. S-1 as first-line treatment in patients with advanced gastric cancer. ( Lu, XY; Wang, ML; Wang, X; Yang, JF; Yu, HG; Zhou, LY, 2013)
"The standard of care for gastric cancer with peritoneal metastasis is chemotherapy."2.77[The updated treatment strategy for gastric cancer with peritoneal metastasis]. ( Ishigami, H; Kaisaki, S; Kitayama, J, 2012)
"Paclitaxel was administered intraperitoneally at 80 mg/m(2)."2.77A preliminary study of single intraperitoneal administration of paclitaxel followed by sequential systemic chemotherapy with S-1 plus paclitaxel for advanced gastric cancer with peritoneal metastasis. ( Furukawa, H; Imamoto, H; Imano, M; Inoue, K; Itoh, T; Kato, H; Nishida, S; Nishikawa, M; Okuno, K; Peng, YF; Satou, T; Shinkai, M; Shiozaki, H; Takeyama, Y; Tsubaki, M; Yasuda, A; Yasuda, T, 2012)
"Eighteen patients with advanced gastric cancer in addition to confirmed peritoneal metastasis using laparoscopy were enrolled in this study."2.76Intraperitoneal infusion of paclitaxel with S-1 for peritoneal metastasis of advanced gastric cancer: phase I study. ( Higashijima, J; Iwata, T; Kurita, N; Miyatani, T; Morimoto, S; Nakao, T; Nishioka, M; Shimada, M; Yoshikawa, K, 2011)
" paclitaxel (PTX) combined with S-1 was carried out in gastric cancer patients with peritoneal metastasis."2.75Phase II study of weekly intravenous and intraperitoneal paclitaxel combined with S-1 for advanced gastric cancer with peritoneal metastasis. ( Hidemura, A; Ishigami, H; Kaisaki, S; Kamei, T; Kato, M; Kitayama, J; Miyato, H; Nagawa, H; Otani, K; Soma, D; Yamashita, H, 2010)
"CEA mRNA (+) patients with gastric cancer were treated postoperatively with S-1 monotherapy."2.75Phase II clinical trial of postoperative S-1 monotherapy for gastric cancer patients with free intraperitoneal cancer cells detected by real-time RT-PCR. ( Ito, S; Kodera, Y; Kojima, T; Mochizuki, Y; Nakanishi, H; Yamamura, Y, 2010)
"Twelve gastric cancer patients with positive cytology were enrolled in this study."2.75Feasibility study of S-1 and intraperitoneal docetaxel combination chemotherapy for gastric cancer with peritoneal dissemination. ( Doki, Y; Fujiwara, Y; Miyata, H; Moon, JH; Mori, M; Nakajima, K; Nishida, T; Takiguchi, S; Yamamoto, K; Yamasaki, M, 2010)
"Patients with advanced gastric cancer, naive to chemotherapy or not refractory to fluoropyrimidine, were enrolled."2.75Phase I study of docetaxel, cisplatin and S-1 in patients with advanced gastric cancer. ( Boku, N; Hironaka, S; Kojima, T; Machida, N; Muro, K; Shitara, K; Taku, K; Ueda, S; Yamazaki, K; Yokota, T, 2010)
" A pharmacokinetic study of PTX was also performed."2.74Phase I pharmacokinetic study of weekly intravenous and intraperitoneal paclitaxel combined with S-1 for advanced gastric cancer. ( Hidemura, A; Ishigami, H; Kaisaki, S; Kamei, T; Kitayama, J; Miyato, H; Nagawa, H; Otani, K; Soma, D; Yamashita, H, 2009)
"The prognosis of advanced gastric cancer patients complicated with positive lavage cytology is poor, similar with that of peritoneal dissemination."2.73[Treatment for advanced gastric cancer with positive lavage cytology-systemic versus intraperitoneal chemotherapy]. ( Iwagami, S; Iwanaga, T; Iwasaki, Y; Matsumoto, H; Nakano, D; Nunobe, S; Ohashi, M; Takahashi, K; Yamaguchi, T, 2008)
"An early detection and treatment of gastric cancer with peritoneal dissemination are rather difficult so that a clinical trial has been neglected."2.73[Neoadjuvant chemotherapy for gastric cancer with peritoneal dissemination]. ( Doki, Y; Fujiwara, Y; Miyata, H; Monden, M; Nishida, T; Takiguchi, S; Yamazaki, M, 2007)
"To determine the safety profile and activity of IP docetaxel combined with S-1 for patients with peritoneal dissemination of gastric cancer, a multi-centric phase I/II study has started."2.73[A multi-centric phase I/II study of intraperitoneal docetaxel combined with S-1 for patients with peritoneal dissemination of gastric cancer]. ( Fujimura, T; Fukushima, N; Fushida, S; Goda, F; Hirono, Y; Imano, M; Kaji, M; Kurita, A; Kurita, N; Nashimoto, A; Ohta, T; Tanemura, H; Tsujitani, S; Watanabe, Y; Yamaguchi, K, 2007)
"We treated 12 patients with advanced gastric cancer with 80 mg/m2 of S-1 for 21 days and 60 mg/m2 of cisplatin (CDDP) on day 8 every 5 weeks."2.71Clinical efficacy of S-1 combined with cisplatin for advanced gastric cancer. ( Baba, H; Endo, K; Ikeda, Y; Kohnoe, S; Okamura, T; Toh, Y; Yamamoto, M, 2003)
"S-1 showed promising activity against gastric cancer with peritoneal dissemination and acceptable toxicity."2.71Pilot study of S-1 in patients with disseminated gastric cancer. ( Hayashi, K; Kitamura, Y; Oguma, H; Sasagawa, T; Takasaki, K, 2003)
"TS-1 is a promising drug for gastric cancer with peritoneal dissemination."2.70[The clinical effect of TS-1 in advanced and recurrent gastric cancer with peritoneal dissemination]. ( Chiba, M; Hayashi, K; Inaba, Y; Kamio, Y; Koyama, M; Ohe, S; Watabe, S, 2002)
"Nearly 70% of gastric cancer recurrences occur as peritoneal dissemination."2.55[A Case of QOL Improvement after Intestinal Stenosis Due to Peritoneal Dissemination of Gastric Cancer in Elderly Patients]. ( Furuke, Y; Ikeda, J; Imura, K; Komatsu, S; Kumano, T; Nakatsugawa, Y; Shimomura, K; Shioaki, Y; Tanaka, Y; Taniguchi, F, 2017)
"Advanced gastric cancers have a poor course in terms of the development of peritoneal carcinomatosis and prognosis, even if the curative resection has been performed."2.55The Importance of Extensive Intraoperative Peritoneal Lavage as a Promising Method in Patients with Gastric Cancer Showing Positive Peritoneal Cytology Without Overt Peritoneal Metastasis and Other Therapeutic Approaches. ( Alemdar, A; Bas, K; Ilhan, E; Ureyen, O, 2017)
"A 64-year-old man with type 3 advanced gastric cancer was referred to our hospital."2.52[A case of highly advanced gastric cancer with peritoneal dissemination -- a histological CR to S-1 and CDDP combination chemotherapy]. ( Ito, S; Ito, Y; Kurahashi, S; Misawa, K; Niwa, Y; Shimizu, Y; Yatabe, Y, 2015)
"An 80-year-old man with type 4 gastric cancer in the mid-gastric region underwent total gastrectomy and D2-No."2.52[Long-Term Disease-Free Survival through Postoperative Chemotherapy in a Case of Gastric Cancer with Peritoneal Dissemination]. ( Ito, M; Kitano, M; Kunishige, T; Matsumoto, S; Migita, K; Nakade, H; Nakajima, Y; Nakatani, M; Tanaka, T; Wakatsuki, K, 2015)
"The patient was a 71-year-old man with gastric cancer of Borrmann type 3 accompanied with N3."2.49[Curative resection of a case of advanced gastric cancer with peritoneal dissemination responding well to combination chemotherapy of docetaxel,cisplatin and S-1]. ( Atsumi, Y; Hasegawa, S; Imada, T; Masuda, M; Nemoto, H; Oshima, T; Rino, Y; Sato, T; Tamagawa, H; Uchiyama, M; Yoshikawa, T; Yukawa, N, 2013)
"Hence, he was diagnosed with advanced jejunal cancer with distant metastasis (T4N1M0 stage)."2.49[A case of jejnal cancer who was controlled peritoneal metastasis, successfully by combination therapy with docetaxel and S-1]. ( Fujita, H; Fujita, J; Funaki, H; Kaida, D; Kinami, S; Kosaka, T; Morioka, E; Nakano, Y; Noguchi, M; Ohnishi, T; Ohno, Y; Tomita, Y; Ueda, N, 2013)
"Without any sign of infection, leukocytosis developed around the 30th POD."2.46Aggressive recurrence of gastric cancer as a granulocyte-colony-stimulating factor-producing tumor. ( Asada, Y; Fujisawa, K; Iida, Y; Kawaguchi, M; Mitsui, T; Miura, S; Munemoto, Y; Sudo, Y; Takehara, A; Terada, T, 2010)
"We aimed to evaluate pancreatic cancer (PC) with positive peritoneal lavage cytology (CY1) outcomes following a change in adjuvant therapy."1.72Postoperative Treatment of Resectable Pancreatic Cancer With Positive Peritoneal Lavage Cytology: A Multicentre Retrospective Study. ( Asagi, A; Furuse, J; Higuchi, R; Konishi, M; Mizuno, N; Morinaga, S; Motoi, F; Nagano, H; Nara, S; Okuyama, H; Shioji, K; Shirakawa, H; Sugimachi, K; Todaka, A; Toshiyama, R; Tsumura, H, 2022)
"This was a real-world study of gastric cancer patients with peritoneal metastasis who have been treated with AS or SOX regimen as first-line chemotherapy."1.72Efficacy of AS versus SOX regimen as first-line chemotherapy for gastric cancer patients with peritoneal metastasis: a real-world study. ( Cui, Y; Li, Q; Li, W; Liu, T; Wang, Y; Yu, S; Yu, Y; Zhang, J; Zhang, L, 2022)
"We report a case of advanced gastric cancer with peritoneal metastasis achieved pathological complete response by chemotherapy."1.56[A Case of Advanced Gastric Cancer with Peritoneal Metastasis Achieved Pathological Complete Response by Chemotherapy(SOX Regimen)]. ( Danno, K; Ikeda, K; Kawagishi, S; Nishigaki, T; Oka, Y; Sugimoto, K; Takahashi, K; Takeyama, H; Taniguchi, H; Tokunaga, T; Toyoda, Y; Yamamoto, H; Yamashita, M, 2020)
" She underwent chemotherapy comprisingintravenous and intraperitoneal paclitaxel combined with S-1."1.51[A Case of Robot-Assisted Conversion Surgery for Gastric Cancer with Peritoneal Dissemination That Responded to Intravenous and Intraperitoneal Paclitaxel Combined with S-1 Chemotherapy]. ( Amano, S; Goto, A; Hanai, T; Hattori, Y; Inaba, K; Kadoya, S; Kato, Y; Kikuchi, K; Nakamura, K; Nakauchi, M; Sugioka, A; Tomatsu, M; Tsuru, Y; Uyama, I, 2019)
"A scirrhous gastric cancer was found, and he was introduced to us."1.51[Multi-Look Staging Laparoscopy and Conversion Surgery for Gastric Cancer with Peritoneal Metastases]. ( Doki, Y; Kurokawa, Y; Makino, T; Miyazaki, Y; Mori, M; Nakajima, K; Noma, T; Takahashi, T; Tanaka, K; Yamasaki, M, 2019)
"Patients with advanced gastric cancer and severe peritoneal metastasis were included if they had massive ascites and/or inadequate oral intake requiring intravenous nutritional support."1.51Fluoropyrimidine with or without platinum as first-line chemotherapy in patients with advanced gastric cancer and severe peritoneal metastasis: a multicenter retrospective study. ( Arai, H; Boku, N; Fukuda, N; Hironaka, S; Iwasa, S; Kawahira, M; Masuishi, T; Minashi, K; Muro, K; Nakajima, TE; Takahari, D; Yasui, H, 2019)
"A 27-year-old woman was diagnosed with gastric cancer complicated peritoneal dissemination and direct invasion to pancreas via staging laparoscopy."1.48[Advanced Gastric Cancer with Peritoneal Dissemination Treated with Conversion Surgery after S-1 and CDDP Chemotherapy - A Case Report]. ( Hasegawa, H; Kakeji, Y; Kanaji, S; Matsuda, T; Matsuda, Y; Nakamura, T; Oshikiri, T; Sumi, Y; Suzuki, S; Ueta, K; Yamamoto, M; Yamashita, K, 2018)
"In the latest Japanese gastric cancer treatment guidelines, PAM plus paclitaxel(PTX)was positioned as a second-line chemotherapy for advanced gastric cancer."1.48[A Case of Advanced Gastric Cancer with Peritoneal Dissemination after Gastrectomy Effectively Treated with Combination Chemotherapy of Ramucirumab and Paclitaxel]. ( Akaishi, T; Hakamada, K; Hara, Y; Kubo, N; Mitsuhashi, Y; Muroya, T; Ogasawara, H; Sato, K; Umemura, K; Umetsu, S; Wajima, N; Wakasa, Y; Yoshida, E; Yoshida, T, 2018)
"A 58-year-old man was diagnosed with gastric cancer in 2006."1.48[A Case of Peritoneal Dissemination of Metastatic Gastric Cancer with Successful Docetaxel and S-1 Combination Therapy]. ( Fujiwara, A; Hama, N; Hamakawa, T; Hirao, M; Kato, S; Kato, T; Maeda, S; Miyake, M; Miyamoto, A; Miyazaki, M; Nakamori, S; Nishikawa, K; Sekimoto, M; Takami, K; Uemura, M, 2018)
"The outcome of gastric cancer patients with peritoneal metastasis remains poor."1.46Peritoneal Lavage CEA mRNA Levels Predict Conversion Gastrectomy Outcomes after Induction Chemotherapy with Intraperitoneal Paclitaxel in Gastric Cancer Patients with Peritoneal Metastasis. ( Ishigami, H; Kitayama, J; Kurihara, M; Satoh, Y; Yamaguchi, H; Yatomi, Y, 2017)
"We report herein a rare case of gastric cancer with peritoneal dissemination who achieved 5- year survival after surgery along with the literature review."1.43[A Patient with Gastric Cancer with Peritoneal Dissemination Who Survived for Five Years after Sequential Chemotherapy with S-1 Followed by Paclitaxel]. ( Kakiuchi, Y; Takashima, H; Urano, S, 2016)
"Advanced sigmoid colon cancer with stenosis was discovered in a man in his 50's who presented with constipation."1.43[Pathological Complete Response to SOX plus Bevacizumab for Treating Stage IV Sigmoid Colon Cancer]. ( Emi, M; Hirabayashi, N; Ibuki, Y; Kagimoto, A; Kaneko, M; Mukaida, H; Takiyama, W; Yoshimitsu, M, 2016)
"Paclitaxel (PTX) was administered via an IP access port implanted in the subcutaneous space."1.42Cell-free and concentrated ascites reinfusion therapy (CART) for management of massive malignant ascites in gastric cancer patients with peritoneal metastasis treated with intravenous and intraperitoneal paclitaxel with oral S-1. ( Emoto, S; Hanafusa, N; Ishigami, H; Ito, T; Kitayama, J; Watanabe, T; Yamaguchi, H, 2015)
"Among 790 gastric cancer patients between 2005 and 2009, 52 cases of CY1 were identified (6."1.42Reduced preoperative serum albumin and absence of peritoneal dissemination may be predictive factors for long-term survival with advanced gastric cancer with positive cytology test. ( Hoshi, K; Hosoda, K; Katada, N; Kikuchi, S; Mieno, H; Moriya, H; Ushiku, H; Watanabe, M; Yamashita, K, 2015)
"The standard treatment of gastric cancer patients with PD is combination therapy with S-1 and cisplatin (SP therapy)."1.42[S-1 plus Cisplatin Combination Therapy for Gastric Cancer with Peritoneal Dissemination]. ( Akita, H; Fujiwara, Y; Gotoh, K; Hara, T; Kobayashi, S; Miyoshi, N; Motoori, M; Noura, S; Ohue, M; Omori, T; Sakon, M; Sugimura, K; Takahashi, H; Yano, M, 2015)
"Treatment of the endometrial cancer with cytoreductive surgery followed by adjuvant chemotherapy was performed first."1.42[A Case of Double Cancers of the Stomach and Endometrium with Peritoneal Metastasis]. ( Arimitsu, H; Chibana, T; Ikeda, A; Imanishi, S; Ishige, F; Kainuma, O; Kobayashi, R; Nabeya, Y; Sasaki, K; Souda, H; Takiguchi, N; Tonooka, T; Yamamoto, H, 2015)
"Here, we report 2 patients with gastric cancer and peritoneal dissemination who were successfully treated with chemotherapy after undergoing treatment for an oncologic emergency caused by peritoneal dissemination."1.42[Introduction of Chemotherapy for Advanced Gastric Cancer Showing Oncologic Emergency Caused by Peritoneal Dissemination--Report of Tow Cases]. ( Akita, H; Fujiwara, Y; Gotoh, K; Kobayashi, S; Miyata, H; Miyoshi, N; Noura, S; Ohue, M; Omori, T; Sakon, M; Sugimura, K; Takahashi, H; Yano, M, 2015)
"Patients with stage III gastric cancer who underwent D2 gastrectomy were enrolled."1.40Survival analysis of adjuvant chemotherapy with S-1 plus cisplatin for stage III gastric cancer. ( Fuse, N; Goto, M; Hamaguchi, T; Ito, S; Katai, H; Konishi, M; Sano, T; Sasako, M; Shirao, K; Takahari, D; Tanigawa, N; Terashima, M; Yasui, H; Yoshimura, K, 2014)
"Peritoneal metastasis of gastric cancer has extremely poor clinical outcomes."1.40Salvage gastrectomy after intravenous and intraperitoneal paclitaxel (PTX) administration with oral S-1 for peritoneal dissemination of advanced gastric cancer with malignant ascites. ( Emoto, S; Ishigami, H; Kaisaki, S; Kitayama, J; Watanabe, T; Yamaguchi, H; Yamashita, H, 2014)
"Management of peritoneal disseminated gastric cancer (GC) remains a challenging problem."1.40Outcome data of patients with peritoneal carcinomatosis from gastric origin treated by a strategy of bidirectional chemotherapy prior to cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in a single specialized center in Japan. ( Canbay, E; Hirano, M; Ichinose, M; Ishibashi, H; Mizumoto, A; Sako, S; Takao, N; Yonemura, Y, 2014)
"Unresectable metastatic colorectal cancer with very slow tumour growth rate does not necessarily require for strong short-interval chemotherapy."1.40Usefulness of monthly chemotherapy for patients with unresectable metastatic colorectal cancer. ( Akiba, T; Enomoto, H; Kawahara, H; Tomoda, M; Watanabe, K; Yanaga, K, 2014)
"Here we report a case of unresected gastric cancer that maintained long tumor dormancy by use of paclitaxel+S-1 combination therapy."1.40[A case of unresected gastric cancer that maintained long tumor dormancy by use of paclitaxel+S-1 combination therapy]. ( Aisu, N; Hoshino, S; Maki, K; Naito, M; Nakagawa, M; Yamashita, Y; Yoshida, Y, 2014)
" The goal of this study was to evaluate the efficacy and safety of combination therapy of cetuximab and S-1 combined with oxaliplatin (SOX) in Chinese patients with advanced gastric cancer."1.40Clinical evaluation of cetuximab combined with an S-1 and oxaliplatin regimen for Chinese patients with advanced gastric cancer. ( Chen, XB; Hua, YW; Kong, Y; Liu, HX; Ma, EM; Yang, W; Zhang, B; Zhang, YL; Zhang, ZD, 2014)
"Gastric adenosquamous carcinoma is a rare malignancy with a poor prognosis."1.40[A case of gastric adenosquamous carcinoma with peritoneal dissemination in which treatment with S-1 plus paclitaxel therapy resulted in improved long-term survival]. ( Hirano, M; Ichinose, M; Mizumoto, A; Ozamoto, Y; Takao, N; Tatsuno, M; Togawa, T; Yamamoto, Y; Yonemura, Y, 2014)
"We report a case of gastric cancer with peritoneal dissemination that was successfully treated with low-dose S-1 or capecitabine chemotherapy over a 5-year period."1.40[A case of gastric cancer with peritoneal dissemination successfully treated with low-dose S-1 or capecitabine chemotherapy for five years]. ( Hara, Y; Minami, Y; Nakamura, T; Ueda, S, 2014)
"We report a case of advanced gastric cancer that was successfully treated with second-line chemotherapy followed by curative conversion gastrectomy."1.40[A case of advanced gastric cancer successfully treated with second-line chemotherapy followed by curative conversion gastrectomy]. ( Asaoka, T; Endo, S; Fujitani, K; Fukuda, Y; Fukui, A; Fushimi, H; Harada, Y; Haraguchi, N; Hirao, M; Ikeda, M; Iwase, K; Kawada, J; Miyake, M; Miyamoto, A; Miyazaki, M; Nakamori, S; Nishikawa, K; Sekimoto, M; Takagi, M; Yamamoto, K, 2014)
"A gastric cancer recurrence with paraaortic lymph node (PALN) metastasis was diagnosed fifteen months after the operation."1.40[A case of successful treatment of peritoneal dissemination from gastric cancer with S-1/DOC chemotherapy]. ( Ebisui, C; Fukuchi, N; Kinuta, M; Murata, K; Nushijima, Y; Okada, K; Okamura, S; Yanagisawa, T; Yokouchi, H, 2014)
"A 35-year-old female with scirrhous stomach cancer (stage IV) was treated with a combination of 5-aminolevulinic acid (ALA), sodium dichloroacetate (DCA), hyperthermotherapy, and immunotherapy as terminal care."1.39A patient with scirrhous stomach cancer treated with combination of hyperthermotherapy and 5-aminolevulinic acid (ALA). ( Goto, S; Kamigaki, T; Saito, M; Yano, K, 2013)
"AFP-producing gastric cancer with peritoneal metastasis has a poor prognosis, but chemotherapy, mainly with S-1 and trastuzumab, was effective for it."1.39[A case of AFP-producing gastric cancer with peritoneal metastasis treated effectively with chemotherapy, mainly using S-1 and trastuzumab]. ( Ishikawa, H; Ishioka, K; Ko, S; Matsusaka, M; Mukogawa, T; Nishiwada, S; Watanabe, A; Yoshikawa, T, 2013)
"Twenty-eight patients with advanced gastric cancer underwent gastrectomy without preoperative chemotherapy."1.39Adjuvant chemotherapy with S-1 followed by docetaxel for gastric cancer and CY1P0 peritoneal metastasis after relatively curative surgery. ( Fujita, I; Kanazawa, Y; Kato, S; Onodera, H; Uchida, E, 2013)
"He survived without recurrence for approximately 2 years after gastrectomy."1.39[A case of advanced gastric cancer with peritoneal dissemination recurrence after gastrectomy effectively treated with combination chemotherapy of S-1 and docetaxel]. ( Ebisui, C; Fukuchi, N; Kato, R; Kinuta, M; Makino, S; Murata, K; Okada, K; Okamura, S; Takeoka, T; Wada, Y; Yanagisawa, T; Yokouchi, H, 2013)
"Rectal stenosis was improved and complete remission was maintained until May 2013."1.39[A case of rectal stenosis due to peritoneal dissemination from gastric cancer that was treated with chemoradiation therapy]. ( Cho, H; Fujikawa, H; Iwasaki, K; Kasahara, A; Masuda, M; Ogata, T; Osaragi, T; Rino, Y; Shirai, J; Sujishi, K; Tsuburaya, A; Yamada, T; Yamamoto, Y; Yoneyama, K; Yoshikawa, T, 2013)
" Two cycles of intraperitoneal chemotherapy with docetaxel combined with S-1, were administrated and gastrectomy with lymph node dissection was performed in cases without macroscopic PC at post-NIPS staging laparoscopy."1.38Intraperitoneal docetaxel combined with S-1 for advanced gastric cancer with peritoneal dissemination. ( Doki, Y; Fujiwara, Y; Kurokawa, Y; Miyata, H; Mori, M; Nakajima, K; Takiguchi, S; Yamasaki, M, 2012)
"We report two cases of advanced gastric cancer."1.38[Two cases of advanced gastric cancer with peritonitis carcinomatosa that showed disappearance of ascites and obtained a good quality of life by using DIF and paclitaxel]. ( Kodama, M; Mekata, E; Okumura, K; Shiogai, Y; Tan, T; Tani, S, 2012)
"A 59-year-old man with type 3 gastric cancer(signet-ring cell carcinoma)underwent simple laparotomy because of peritoneal dissemination."1.38[A long-surviving patient with unresectable advanced gastric cancer treated with S-1 and biweekly paclitaxel combination chemotherapy as second-line treatment]. ( Goto, M; Hirata, Y; Kawahara, Y; Kitamura, M; Nakayama, M; Ohta, R; Oneyama, M; Sekikawa, K; Shimoda, Y; Takahashi, Y, 2012)
"We report a gastric cancer patient with positive peritoneal lavage cytology (CY1) who achieved 20-month progression free survival by S-1 monotherapy."1.38[S-1 monotherapy achieved twenty-month survival for peritoneal lavage cytology-positive gastric cancer patient undergoing noncurative resection]. ( Kiyokawa, T; Nishida, M; Seto, Y; Shimoyama, S, 2012)
"Borrmann-type 3 gastric cancer with hemorrhaging was revealed by stomach endoscopy."1.37[A case of gastric cancer with peritoneal dissemination successfully treated by S-1/paclitaxel combination chemotherapy]. ( Shoji, T, 2011)
"Gluteal recurrence of the original gastric cancer was suggested, and systemic chemotherapy consisting of S-1 at 100 mg/day (3 weeks on, 1 week off) and CDDP (day 8) was started."1.37Good response chemotherapy for late-recurring gastric cancer in the gluteals, with peritoneal and retroperitoneal dissemination. ( Deguchi, R; Iwata, Y; Mine, T; Numata, M; Ogasawara, F; Ohtani, Y; Sakuma, T; Sato, S; Takashimizu, S, 2011)
" We judged that curative resection was impossible and finished the operation after giving an intra-abdominal dosage of cisplatin(CDDP)at 85mg."1.37[A case of gastric carcinoma with peritoneal metastasis successfully treated by combination chemotherapy of S-1 and cisplatin]. ( Gon, H; Ishida, T; Iwasaki, T; Kanemitsu, K; Nakajima, T; Okuda, T; Tanaka, K; Toyokawa, A; Yamashita, H, 2011)
"We report two cases of advanced gastric cancer successfully treated with combination S-1 and docetaxel (DOC) therapy."1.36[Two cases of advanced gastric cancer with peritoneal dissemination, and Virchow's metastases successfully treated by combination therapy of S-1 and docetaxel]. ( Hasegawa, H; Kijima, T; Kitahara, M; Kubo, H; Miyahara, M; Tada, K, 2010)
"Paclitaxel 50mg/m2 was administered on days 1 and 8."1.36[Combination of S-1 and paclitaxel for advanced/recurrent gastric cancer patients with peritoneal metastasis, feasibility study (OGSG0401)]. ( Fujitani, K; Furukawa, H; Kimura, Y; Machida, H; Shimokawa, T; Takiuchi, H; Tominaga, K; Tsujinaka, T; Yamamoto, M; Yano, H, 2010)
" Weekly intravenous and intraperitoneal PTX combined with S-1 was highly effective in gastric cancer with malignant ascites."1.36Weekly intravenous and intraperitoneal paclitaxel combined with S-1 for malignant ascites due to advanced gastric cancer. ( Hidemura, A; Ishigami, H; Kaisaki, S; Kamei, T; Kato, M; Kitayama, J; Miyato, H; Nagawa, H; Otani, K; Soma, D; Yamashita, H, 2010)
"In advanced gastric cancer with peritoneal metastasis, adjuvant chemotherapy after primary tumor resection showed considerably poor prognosis with a median survival time of only 232 days."1.36[Strategy of treatment for gastric cancer with peritoneal metastasis]. ( Adachi, T; Hatoh, T; Matsui, K; Oshita, H; Tanemura, H; Yamada, M, 2010)
"Paclitaxel was administered at 120 mg/m(2) on day 1 and S-1 was administered orally at 80 mg/m(2) for 14 consecutive days, followed by a 1-week rest, as one course."1.36Pilot study of a combination of S-1 and paclitaxel for patients with peritoneal metastasis from gastric cancer. ( Egawa, C; Miki, H; Nakahira, S; Nakata, K; Okada, K; Okamura, S; Sugimoto, K; Suzuki, R; Takatsuka, Y; Takeno, A; Tamura, S; Uji, K; Yoshida, A, 2010)
"No re-growth of gastric cancer has been seen for 9 months with this chemotherapy."1.36[A very elderly case of recurrent gastric cancer with peritoneal dissemination effectively treated by combination chemotherapy of docetaxel (DOC) and S-1]. ( Hachisuka, T; Hattori, K; Kinoshita, T; Miyauchi, M; Mori, T; Shikano, T; Shinohara, M; Yamamoto, T, 2010)
"A 75-year-old man with advanced gastric cancer underwent distal gastrectomy with lymph node dissection(D1)and Roux-en Y reconstruction."1.35[A case of Stage IV gastric cancer with liver and peritoneal metastases responding completely to tailored S-1/CPT- 11 combination therapy]. ( Arai, H; Kashiwabara, M; Maruyama, H; Matsuda, A; Matsushita, A; Matsutani, T; Miyamoto, M; Mizutani, T; Nishi, Y; Sasajima, K; Suzuki, S; Tajiri, T; Yanagi, K; Yokoyama, T, 2008)
"They were diagnosed with unresectable gastric cancer with severe peritoneal dissemination by staging laparoscopy, or with metastasis to the transverse colon."1.35Pilot study of intraperitoneal administration of paclitaxel and oral S-1 for patients with peritoneal metastasis due to advanced gastric cancer. ( Miki, H; Miyake, T; Nakahira, S; Nakata, K; Okada, K; Okamura, S; Sugimoto, K; Suzuki, R; Takatsuka, Y; Tamura, S; Yoshimura, M, 2008)
"The patient was diagnosed with typeIII gastric cancer by gastroendoscopy postoperatively."1.35[A case of perforated gastric cancer in which resection for elimination was possible S-1/CDDP combined chemotherapy for peritonitis carcinomatosa]. ( Itakura, T; Sugimoto, T; Uesaka, K, 2009)
"Two unresectable advanced gastric cancer cases with peritoneal metastases were successfully treated by the combination therapy of S-1 and paclitaxel."1.35[Two advanced gastric cancer cases with peritoneal metastases successfully treated by s-1/paclitaxel combination therapy]. ( Ando, T; Furuta, R; Goto, H; Ina, K; Kataoka, T; Kayukawa, S; Masaki, A; Nagao, S; Nishio, T, 2009)
"Abdominal CT scan revealed pancreatic cancer with massive ascites showing peritoneal dissemination, combined with lymph node and liver metastases."1.35[A resected case of effective treatment with S-1/gemcitabine and Paclitaxel combination chemotherapy for advanced pancreatic cancer with peritoneal and liver metastases]. ( Fushida, S; Kimura, H; Mukawa, A, 2009)
"We encountered a patient with gastric cancer demonstrating peritoneal dissemination, who was successfully treated by combination therapy using S-1 and docetaxel."1.35[A case of gastric cancer with peritoneal dissemination-efficacy of combination therapy with S-1 and docetaxel]. ( Futagawa, S; Kitajima, M; Konishi, N; Marusasa, T; Nishimura, K; Ochiai, T; Satoh, G; Watanabe, T, 2009)
"The prognosis of gastric cancer patients with peritoneal dissemination is poor."1.35Induction chemotherapy with S-1 plus cisplatin followed by surgery for treatment of gastric cancer with peritoneal dissemination. ( Hosogi, H; Obama, K; Okabe, H; Sakai, Y; Ueda, S, 2009)
"The subjects were type 4 advanced gastric cancer cases from October 2002 to December 2007 who underwent st-lap, as well as 7 P0 and CY0 [P(-)] cases (the operative group), and 18 P(+) cases which underwent chemotherapy (the chemotherapy group)."1.35[Outcome of therapy for type 4 gastric cancer with peritoneal metastasis--diagnosis by laparoscopy and effect of chemotherapy]. ( Egawa, C; Miki, H; Nakahira, S; Nakata, K; Okada, K; Okamura, S; Sugimoto, K; Suzuki, R; Takatsuka, Y; Tamura, S; Uji, K; Yoshida, A; Yoshimura, M; Yoshioka, Y, 2009)
"Most gastric cancer patients with peritoneal dissemination die within a few months, and there is no standard treatment for peritoneal dissemination from gastric cancer."1.35[A case of gastric cancer with peritoneal dissemination which has been alive more than three years responding to intraperitoneal chemotherapy]. ( Asami, S; Hirata, M; Idani, H; Kin, H; Kubo, S; Kumano, K; Kurose, Y; Muro, M; Nojima, H; Sasaki, H; Takakura, N; Yamashita, T; Yoshioka, T, 2009)
"Gemcitabine (1,000 mg/m2) was intravenously administered 3 times (on days 1, 8, 15) every 4 weeks (days 1-28) as 1 course."1.35[A partial response to S-1 as second-line chemotherapy in a patient with unresectable pancreatic cancer]. ( Egawa, T; Hayashi, S; Ito, Y; Mihara, K; Nagashima, A; Ohashi, M; Takahashi, T, 2009)
"We report a case of gastric cancer with ascites treated with chemotherapy."1.34[Case of advanced gastric cancer successfully treated with chemotherapy of weekly paclitaxel]. ( Arakawa, T; Fujii, K; Kaneda, K; Kawamura, C; Kayo, S; Mizuyama, Y; Nakagawa, H; Ueda, Y; Uno, H, 2007)
"In general, treatment for gastric cancer with peritoneal dissemination or recurrent gastric cancer is outside the scope of surgery."1.33[A case of a nonresected gastric cancer with peritoneal dissemination maintained on TS-1 and docetaxel combination chemotherapy with good QOL]. ( Kawasaki, H; Kobori, H; Maruyama, M; Sasaki, M; Seino, K; Shibata, S; Sugiyama, Y; Yamada, K, 2005)
"She was diagnosed as remnant gastric cancer with multiple bone metastasis and peritoneal dissemination."1.33[A case of remnant gastric cancer with multiple bone metastasis and peritoneal dissemination; efficacy of combination therapy of docetaxel and TS-1]. ( Hamai, Y; Hihara, J; Tanabe, K; Toge, T; Ukon, K; Yoshida, K, 2005)
"One case with type 4 gastric cancer who had right hydronephrosis and malignant abdominal ascites underwent curative resection after successful treatment with TS-1."1.33[Peritoneal dissemination of scirrhous type 4 gastric cancers]. ( Aoyagi, K; Imaizumi, T; Koufuji, K; Miyagi, M; Murakami, N; Shirouzu, K; Yano, S, 2005)
"In advanced gastric cancer, the frequency of relapses such as metastasis to the peritoneum is high."1.33[Prediction and treatment of peritoneal dissemination in gastric cancer]. ( Aratake, K; Itabashi, M; Kameoka, S; Mitsuhashi, M; Ogawa, S; Seshimo, A; Shirotani, N, 2005)
"We reported 2 cases with advanced gastric cancer, successfully treated with TS-1 and CDDP."1.33[Two cases of advanced gastric cancer, successfully treated with TS-1/CDDP combination chemotherapy--case report]. ( Ando, K; Ishihara, C; Ishiwa, N; Morinaga, S; Noguchi, Y; Ogoshi, T; Shotsu, M; Takeda, A; Yamamoto, Y; Yoshida, S; Yoshikawa, T, 2005)
" There were less severe adverse events concerning paclitaxel despite of the second line therapy of TS-1, and 80 percent of all therapeutic courses was at an outpatient clinic."1.33[Safety and efficacy of chemotherapy using TS-1 followed by paclitaxel for advanced or recurrent gastric cancer with peritoneal dissemination]. ( Banba, T; Hatakeyama, K; Kanda, T; Kosugi, S; Ohashi, M; Tanabe, T; Yajima, K, 2005)
"By a diagnosis of descending colon cancer, descending colon ablative operation and D1 lymph node dissection were performed on April 22, 2004."1.33[A case of peritoneal dissemination disappeared by CPT-11 + TS-1 combination chemotherapy]. ( Fujishima, M; Fukunaga, M; Furukawa, H; Imamura, H; Kawasaki, T; Kishimoto, T; Kondo, M; Masutani, S; Nakayama, T; Ooshiro, R; Takemoto, H; Tanaka, J; Tatsuta, M; Yamamoto, K, 2005)
"Paclitaxel was ineffective, and so we opted for weekly administration of low-dose CDDP combined with TS-1, which led to the third recovery."1.33[A case of gastric cancer with peritoneal dissemination who achieved five-year survival by successive treatments with TS-1 alone and in combination with other drugs]. ( Aiko, S; Ishizuka, T; Kumano, I; Maehara, T; Sakano, T; Sugiura, Y; Yoshizumi, Y, 2006)
"Upper GI endoscopy revealed type 3 gastric cancer from the anglus to the cardia."1.33[A case of nonresected gastric cancer with peritoneal dissemination maintained on TS-1, cisplatin (CDDP) and docetaxel combination chemotherapy with good QOL]. ( Kimura, H; Koyama, F, 2006)
"We report a case of gastric cancer with peritoneal recurrence that responded to chemotherapy with paclitaxel and TS-1."1.33[A case of recurrent gastric cancer with peritoneal dissemination successfully treated over 1 year 8 months with combined chemotherapy of paclitaxel and TS-1]. ( Aihara, T; Kim, C; Miki, H; Nakata, K; Ohzato, H; Okada, K; Okamura, S; Sugimoto, K; Takatsuka, Y; Takiuchi, D; Tamura, S; Tomita, N, 2006)
"The response of gastric cancer with peritoneal dissemination to systemic chemotherapy may be negatively affected by poor drug delivery due to the blood-peritoneal barrier."1.33Pharmacokinetics of S-1 in patients with peritoneal dissemination of gastric cancer. ( Hatori, S; Imada, T; Kunisaki, C; Oshima, T; Yamada, R, 2006)
"Further examination showed an advanced gastric cancer with peritoneal dissemination."1.33[A case of advanced gastric cancer with peritoneal dissemination responding remarkably to TS-1/CDDP combination chemotherapy]. ( Asagoe, K; Azechi, H; Inoue, F; Ishii, K; Katsurada, A; Kondo, M; Nishikawa, K; Nishiura, H; Nonami, M; Otani, Y; Saiga, T; Shigemori, M; Suwa, H; Tojo, M, 2006)
"Human gastric cancer cells (MKN-45) were injected into the peritoneal cavity of nude mice."1.32Prevention of peritoneal metastasis of human gastric cancer cells in nude mice by S-1, a novel oral derivative of 5-Fluorouracil. ( Fujiwara, Y; Monden, M; Mori, T; Takiguchi, S; Tamura, S; Yano, M; Yasuda, T, 2003)
"S-1 appears to be safe and highly active, with favorable longterm survival in patients with metastatic gastric cancer, particularly in those with diffuse-type histology and peritoneal metastasis."1.32Efficacy and safety profile of S-1 in patients with metastatic gastric cancer in clinical practice: results from a post-marketing survey. ( Boku, N; Doi, T; Hamamoto, Y; Kawai, H; Mera, K; Muto, M; Nagashima, F; Ohtsu, A; Sano, Y; Yano, T; Yoshida, S, 2003)
"We treated a patient with gastric cancer considered to be unresectable due to peritoneal metastasis, who responded remarkably to treatment with TS-1."1.32[A case of peritoneal metastasis of gastric cancer responding to TS-1, administered for four consecutive weeks with two-week rests]. ( Adachi, I; Emoto, T; Fujii, M; Fujikawa, M; Kamei, A; Komaki, T; Naka, Y; Nezu, R; Yokota, T; Yoshikawa, K; Yoshioka, Y, 2003)
"After the 5th course, the stenosis of colon and ascites had disappeared in a barium enema and CT scan, respectively."1.32[A case of advanced type 4 gastric cancer with peritonitis dissemination, navel metastasis effectively treated with combined chemotherapy of biweekly paclitaxel (TXL) and TS-1]. ( Aikou, T; Arima, H; Hamada, N; Hokita, S; Ishigami, S; Maeda, S; Miyazono, F; Natsugoe, S; Takao, S; Takatori, H, 2003)
"An umbilical metastasis of gastric cancer is known as Sister Mary Joseph's nodule."1.32[A case of gastric cancer with umbilical metastasis that responded to TS-1 with low-dose cis-platinum]. ( Fukunaga, S; Hirakawa, K; Inoue, T; Ishikawa, T; Kato, Y; Nakata, B; Nishiguchi, Y; Ohira, M; Takashima, T; Yamagata, S; Yashiro, M, 2004)
"Although the prognosis of recurrent gastric cancer with peritoneal dissemination was extremely poor, this case might suggest a possibility that intensive therapies are useful in maintaining the quality of life and improving survival."1.32[A case of recurrent gastric cancer with peritoneal dissemination successfully treated with DJ stents against bilateral hydronephrosis and chemotherapy]. ( Ebisui, C; Fujimoto, T; Fukuchi, N; Hasuike, Y; Hayashi, N; Izawa, H; Sakita, I; Souma, I; Yoshida, T, 2004)
"We report three patients with recurrent gastric cancer responding to TS-1 therapy after combination chemotherapy with 5-fluorouracil, mitomycin C and cisplatin."1.31[Three cases of recurrent gastric cancer responding to TS-1 therapy following combination therapy with 5-fluorouracil, mitomycin C and cisplatin]. ( Hayashi, K; Iijima, S; Koyama, Y; Miyazawa, K; Morikawa, A; Murakami, M; Okabe, R; Ozaki, K; Sugiyama, A; Suzuki, A, 2002)

Research

Studies (215)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's92 (42.79)29.6817
2010's115 (53.49)24.3611
2020's8 (3.72)2.80

Authors

AuthorsStudies
Mei, Y1
Shi, M1
Zhu, Z2
Yuan, H1
Yan, C1
Li, C1
Feng, T1
Yan, M1
Zhang, J2
Todaka, A1
Nara, S1
Motoi, F2
Morinaga, S2
Toshiyama, R1
Higuchi, R1
Konishi, M2
Shirakawa, H1
Tsumura, H1
Okuyama, H1
Nagano, H1
Shioji, K1
Sugimachi, K1
Asagi, A1
Mizuno, N1
Furuse, J1
Zhang, L1
Wang, Y2
Li, W1
Yu, S1
Li, Q2
Yu, Y2
Liu, T2
Cui, Y2
Kobayashi, D1
Ishigami, H14
Kanda, M1
Tanaka, C1
Yamaguchi, H8
Kitayama, J13
Kodera, Y5
Yamaguchi, T4
Takashima, A1
Nagashima, K1
Makuuchi, R1
Aizawa, M1
Ohashi, M6
Tashiro, K1
Yamada, T4
Kinoshita, T2
Hata, H1
Kawachi, Y1
Kawabata, R1
Tsuji, T1
Hihara, J2
Sakamoto, T1
Fukagawa, T1
Katai, H3
Higuchi, K1
Boku, N7
Naruse, T1
Hirono, Y3
Kurebayashi, H1
Katayama, H2
Sawai, K1
Morikawa, M1
Koneri, K1
Tamaki, M1
Murakami, M3
Goi, T1
Nakamura, M2
Ojima, T1
Katsuda, M1
Hayata, K1
Kitadani, J1
Nakamori, M2
Yamaue, H2
Nishigaki, T2
Oka, Y2
Taniguchi, H1
Takahashi, K6
Kawagishi, S1
Yamashita, M1
Takeyama, H1
Danno, K1
Toyoda, Y1
Tokunaga, T1
Sugimoto, K10
Yamamoto, H2
Ikeda, K2
Kano, K1
Aoyama, T3
Maezawa, Y1
Nakajima, T4
Sato, T2
Oshima, T3
Rino, Y4
Masuda, M4
Ogata, T5
Cho, H7
Yoshikawa, T11
Satoh, Y1
Kurihara, M1
Yatomi, Y1
Nakayama, I1
Chin, K2
Matsushima, T1
Takahari, D4
Ogura, M1
Shinozaki, E1
Suenaga, M1
Ozaka, M1
Wakatsuki, T1
Ichimura, T1
Hiroki, O1
Yamaguchi, K5
Shimaoka, H1
Shibata, R1
Hosoda, Y1
Hirano, Y1
Munechika, T1
Yonemitsu, K1
Ishii, Y2
Okamoto, T1
Maeno, H1
Noritomi, T1
Yoshida, T3
Sueishi, K1
Miura, S2
Ueda, N2
Fujita, H2
Kinami, S2
Nakano, Y2
Kosaka, T2
Sakata, N1
Nishino, R1
Shimomura, K2
Furuke, Y1
Tanaka, Y2
Kumano, T1
Komatsu, S1
Imura, K1
Ikeda, J2
Taniguchi, F2
Shioaki, Y2
Nakatsugawa, Y1
Matsuda, Y1
Nakamura, T3
Ueta, K1
Hasegawa, H2
Yamamoto, M7
Kanaji, S1
Yamashita, K2
Oshikiri, T1
Matsuda, T1
Sumi, Y1
Suzuki, S2
Kakeji, Y1
Shinkai, M3
Imano, M5
Chiba, Y2
Hiraki, Y2
Kato, H3
Iwama, M2
Shiraisi, O1
Yasuda, A3
Tsubaki, M3
Nishida, S3
Kimura, Y5
Yasuda, T6
Shiraishi, O1
Saito, K2
Isayama, H4
Nakai, Y3
Takahara, N2
Ishigaki, K1
Takeda, T1
Hakuta, R1
Saito, T1
Uchino, R1
Kishikawa, T1
Hamada, T1
Mizuno, S1
Sasaki, T4
Kogure, H3
Matsubara, S1
Yamamoto, N2
Ijichi, H2
Tateishi, K2
Tada, M3
Koike, K3
Muroya, T1
Wajima, N1
Kubo, N2
Yoshida, E1
Akaishi, T1
Umetsu, S1
Wakasa, Y1
Sato, K1
Mitsuhashi, Y1
Umemura, K1
Ogasawara, H1
Hara, Y2
Hakamada, K1
Okada, K12
Kawanaka, S1
Taniguchi, S1
Adachi, S1
Yoshioka, S1
Ueshima, S2
Higaki, N1
Hayashida, H1
Nezu, R2
Kato, S2
Nishikawa, K5
Hirao, M3
Hamakawa, T2
Fujiwara, A1
Maeda, S2
Uemura, M1
Miyake, M2
Hama, N1
Miyamoto, A2
Miyazaki, M3
Kato, T3
Takami, K1
Nakamori, S2
Sekimoto, M2
Hattori, Y1
Nakauchi, M1
Tsuru, Y1
Amano, S1
Goto, A1
Tomatsu, M1
Nakamura, K3
Kikuchi, K1
Kadoya, S1
Inaba, K1
Kato, Y2
Hanai, T1
Sugioka, A1
Uyama, I1
Noma, T1
Takahashi, T7
Miyazaki, Y2
Kurokawa, Y4
Tanaka, K4
Makino, T1
Nakajima, K6
Yamasaki, M5
Mori, M5
Doki, Y7
Terashima, M3
Iwasaki, Y5
Mizusawa, J2
Ito, Y5
Kaji, M3
Yamada, M2
Kurita, A2
Takagi, M2
Sano, T2
Sasako, M2
Arai, H2
Iwasa, S1
Kawahira, M1
Yasui, H5
Masuishi, T1
Muro, K4
Minashi, K2
Hironaka, S3
Fukuda, N1
Nakajima, TE1
Fushida, S3
Kinoshita, J1
Goda, F4
Yagi, Y3
Oyama, K2
Sudo, Y2
Watanabe, Y2
Fujimura, T2
Hamaguchi, T1
Yoshimura, K1
Ito, S4
Fuse, N2
Goto, M3
Tanigawa, N1
Shirao, K2
Saito, M1
Yano, K1
Kamigaki, T1
Goto, S1
Emoto, S5
Yamashita, H8
Watanabe, T5
Nishiwada, S1
Watanabe, A1
Ishioka, K1
Mukogawa, T1
Matsusaka, M1
Ko, S1
Ishikawa, H2
Katayama, K1
Nishino, T1
Takahashi, Y2
Tanaka, T4
Okitsu, H1
Okitsu, N1
Kaisaki, S5
Watanabe, K2
Kawahara, H2
Enomoto, H2
Toyama, Y1
Akiba, T2
Yanaga, K2
Nemoto, H1
Uchiyama, M1
Atsumi, Y1
Hasegawa, S2
Tamagawa, H1
Yukawa, N1
Imada, T3
Kanazawa, Y1
Fujita, I1
Onodera, H1
Uchida, E1
Canbay, E2
Mizumoto, A3
Ichinose, M2
Ishibashi, H2
Sako, S1
Hirano, M2
Takao, N2
Yonemura, Y4
Ohnishi, T1
Fujita, J1
Morioka, E1
Kaida, D1
Ohno, Y1
Tomita, Y1
Noguchi, M1
Funaki, H1
Shirai, J2
Fujikawa, H2
Iwasaki, K2
Tsuburaya, A8
Sujishi, K2
Osaragi, T2
Yoneyama, K2
Kasahara, A2
Yamamoto, Y5
Wada, Y2
Ebisui, C4
Kato, R2
Makino, S2
Takeoka, T1
Yanagisawa, T3
Okamura, S10
Fukuchi, N3
Murata, K3
Yokouchi, H3
Kinuta, M3
Sasaki, K2
Fujiwara, Y12
Kishi, K1
Motoori, M2
Sugimura, K3
Miyoshi, N3
Akita, H3
Gotoh, K3
Takahashi, H4
Marubashi, S1
Noura, S3
Ohue, M3
Yano, M6
Sakon, M3
Tomoda, M1
Hayashi, T3
Tanabe, K2
Morita, S2
Miyashita, Y1
Sakamoto, J1
Naito, M1
Aisu, N1
Maki, K1
Nakagawa, M1
Yoshida, Y1
Hoshino, S1
Yamashita, Y3
Zhang, ZD1
Kong, Y1
Yang, W1
Zhang, B1
Zhang, YL1
Ma, EM1
Liu, HX1
Chen, XB1
Hua, YW1
Koga, H1
Miyoshi, A1
Nakamura, J1
Ide, T1
Kitahara, K1
Noshiro, H1
Yamamura, A1
Ono, F1
Hiraga, M1
Omura, N1
Takano, N1
Sato, H1
Toyama, S1
Onochi, S1
Ozamoto, Y1
Togawa, T1
Tatsuno, M1
Ueda, S3
Minami, Y1
Osaki, T1
Kuroda, H1
Nagai, S1
Watanabe, H1
Takahashi, S2
Kurisu, Y1
Ikeguchi, M1
Shiozaki, S1
Satoh, D1
Matsukawa, H1
Mimura, N1
Taguchi, K1
Araki, H1
Toshima, T1
Miyake, S1
Miyoshi, H1
Yoshida, K2
Choda, Y1
Tokumoto, N1
Kanazawa, T1
Harano, M1
Ojima, Y1
Idani, H2
Okajima, M1
Ninomiya, M2
Tsukamoto, T2
Kanazawa, A1
Shimizu, S2
Sakae, M1
Ohira, G1
Yoshii, M1
Ishikawa, A1
Mori, Y2
Kotsuka, M1
Goto, W1
Kurihara, S1
Tashima, T1
Deguchi, S1
Tachimori, A1
Tamamori, Y1
Yamamoto, A1
Inoue, T3
Nishiguchi, Y2
Kawada, J1
Fujitani, K3
Yamamoto, K4
Fukui, A1
Fushimi, H1
Endo, S1
Iwase, K2
Harada, Y1
Fukuda, Y1
Haraguchi, N1
Asaoka, T1
Ikeda, M1
Nushijima, Y1
Iwai, N1
Wakabayashi, N1
Matsumoto, N1
Morita, Y1
Tanaka, N3
Yoriki, H1
Fujii, K2
Takada, R1
Takaya, H1
Masuzawa, A1
Takami, S1
Kataoka, K1
Kurahashi, S1
Misawa, K1
Niwa, Y2
Yatabe, Y1
Shimizu, Y2
Miyata, H7
Takiguchi, S9
Ito, T1
Hanafusa, N1
Ushiku, H1
Katada, N1
Hosoda, K1
Moriya, H1
Mieno, H1
Kikuchi, S2
Hoshi, K1
Watanabe, M1
Nishina, T2
Gotoh, M3
Shimada, Y1
Hamamoto, Y2
Kawai, H2
Nakayama, N1
Amagai, K2
Ohtsu, A3
Bando, H1
Yamada, Y2
Tanabe, S1
Sugimoto, N1
Tsuji, A2
Imamura, H3
Tsuda, M1
Fujii, H1
Shimada, K2
Miwa, H1
Hamada, C1
Hyodo, I1
Cao, C1
Kuang, M1
Xu, W1
Zhang, X1
Chen, J1
Tang, C1
Hara, T1
Omori, T2
Kobayashi, S2
Nakao, K1
Shitara, K4
Fukunari, H1
Okajima, C1
Watanabe, G1
Kobayashi, R1
Takiguchi, N1
Nabeya, Y1
Ikeda, A1
Souda, H1
Kainuma, O1
Tonooka, T1
Imanishi, S1
Arimitsu, H1
Chibana, T1
Ishige, F1
Saito, H2
Suematsu, Y1
Hiratsuka, M1
Suda, H1
Takahashi, M1
Omori, K1
Ishibashi, Y1
Morita, A1
Wakabayashi, K1
Nakade, H1
Matsumoto, S3
Wakatsuki, K2
Migita, K2
Ito, M2
Kunishige, T1
Kitano, M1
Nakatani, M1
Nakajima, Y2
Urano, S1
Kakiuchi, Y1
Takashima, H1
Li, Y1
Coccolini, F1
Glehen, O1
Sugarbaker, PH1
Morris, D1
Moran, B1
Gonzaletz-Moreno, S1
Deraco, M1
Piso, P1
Elias, D1
Batlett, D1
Verwaal, V1
Mahtem, H1
Ibuki, Y1
Yoshimitsu, M1
Emi, M1
Mukaida, H1
Hirabayashi, N1
Kagimoto, A1
Kaneko, M2
Takiyama, W1
Suzuki, K1
Yajima, K2
Yuu, K1
Oohinata, R1
Amaki, M1
Ilhan, E1
Alemdar, A1
Ureyen, O1
Bas, K1
Asakage, M1
Satoi, S1
Fujii, T1
Yanagimoto, H1
Kurata, M1
Yamada, S1
Yamamoto, T2
Mizuma, M1
Honda, G1
Unno, M1
Kon, M1
Ishiguro, T1
Fukuchi, M1
Ogura, T1
Muta, Y1
Mochiki, E1
Ishida, H2
Tokunaga, Y1
Sasaki, H2
Saitou, T1
Matsutani, T1
Mizutani, T1
Miyamoto, M1
Maruyama, H1
Yokoyama, T2
Yanagi, K1
Matsushita, A1
Kashiwabara, M1
Matsuda, A1
Nishi, Y1
Sasajima, K1
Tajiri, T1
Tokunaga, M1
Tanabe, Y1
Nasu, T1
Abe, Y1
Mitsuyama, S1
Toyoshima, S1
Ina, K2
Kataoka, T2
Takeuchi, Y1
Fukuoka, T1
Miwa, T1
Nishio, T2
Furuta, R2
Masaki, A2
Mori, F1
Kayukawa, S2
Nagao, S2
Ando, T2
Goto, H2
Lee, JL1
Kang, YK1
Kang, HJ1
Lee, KH1
Zang, DY1
Ryoo, BY1
Kim, JG1
Park, SR1
Kang, WK1
Shin, DB1
Ryu, MH1
Chang, HM1
Kim, TW1
Baek, JH1
Min, YJ1
Tanabe, D1
Kondou, K1
Uchiyama, T1
Noda, K1
Tamura, S11
Miki, H8
Miyake, T1
Yoshimura, M2
Suzuki, R4
Nakahira, S5
Nakata, K7
Takatsuka, Y8
Yamazaki, M2
Nishida, T3
Nunobe, S1
Iwanaga, T3
Iwagami, S1
Matsumoto, H3
Nakano, D3
Sugimoto, T1
Itakura, T1
Uesaka, K1
Otani, K3
Kamei, T3
Soma, D3
Miyato, H3
Hidemura, A3
Nagawa, H3
Kato, M2
Kimura, H2
Mukawa, A1
Kumagai, K1
Saikawa, Y3
Fukuda, K2
Ito, R1
Igarashi, T1
Tsuwano, S1
Nakamura, R3
Takeuchi, H1
Kitagawa, Y2
Kitajima, M3
Satoh, G1
Marusasa, T1
Konishi, N1
Ochiai, T2
Nishimura, K1
Futagawa, S1
Okabe, H1
Obama, K1
Hosogi, H1
Sakai, Y1
Seshimo, K1
Kanagawa, T1
Oishi, M1
Kodera, M1
Yamamura, M1
Katoh, H2
Ikeda, H1
Yokomichi, N1
Kobayashi, K1
Takita, K1
Koizumi, W1
Takiuchi, H3
Komatsu, Y1
Uji, K2
Yoshida, A2
Yoshioka, Y3
Egawa, C3
Asami, S1
Kubo, S1
Kurose, Y1
Nojima, H1
Yoshioka, T1
Muro, M1
Kumano, K1
Hirata, M1
Yamashita, T1
Kin, H1
Takakura, N1
Kametaka, H1
Makino, H1
Koyama, T1
Seike, K1
Egawa, T1
Mihara, K1
Hayashi, S2
Nagashima, A1
Kubo, H1
Kijima, T1
Kitahara, M1
Tada, K1
Miyahara, M1
Machida, H1
Tominaga, K1
Yano, H1
Shimokawa, T2
Tsujinaka, T1
Furukawa, H4
Murayama, Y1
Sano, I1
Doi, Y1
Iwasaki, R1
Chatani, T1
Horiki, M1
Kitada, M1
Okuno, M1
Kondo, S1
Fukuda, H1
Kashihara, T1
Kawaguchi, M1
Asada, Y1
Terada, T1
Takehara, A1
Munemoto, Y1
Fujisawa, K1
Mitsui, T1
Iida, Y1
Tanemura, H2
Oshita, H1
Hatoh, T1
Adachi, T1
Matsui, K1
Mochizuki, Y2
Kojima, T3
Nakanishi, H2
Yamamura, Y2
Sasahira, N2
Hirano, K2
Tsujino, T1
Omata, M1
Moon, JH1
Takeno, A2
Yamazaki, K1
Taku, K1
Yokota, T2
Machida, N1
Wakahara, T1
Toyokawa, A2
Tomono, A1
Tani, S2
Yamamichi, T1
Nishioka, N1
Gon, H2
Kanemitsu, K2
Okuda, T2
Hamabe, Y1
Iwasaki, T2
Ishida, T3
Akagi, T1
Etoh, T1
Eguchi, H1
Hiroishi, K1
Ueda, Y3
Yasuda, K1
Noguchi, T2
Shiraishi, N1
Kitano, S1
Shikano, T2
Hattori, K1
Hachisuka, T1
Mori, T4
Shinohara, M1
Miyauchi, M1
Sadahiro, S1
Suzuki, T1
Maeda, Y1
Tanaka, A1
Kanoda, H1
Kamijo, A1
Kanemura, T1
Yanai, A1
Kobayashi, M1
Kadono, M1
Ohinata, R2
Shoji, T1
Kurita, N2
Shimada, M1
Iwata, T1
Nishioka, M1
Morimoto, S1
Yoshikawa, K2
Higashijima, J1
Miyatani, T1
Nakao, T1
Zaima, C1
Kanai, M1
Ishikawa, S1
Kawaguchi, Y1
Masui, T2
Nishimura, T1
Yanagihara, K1
Chiba, T1
Mimori, T1
Sakuma, T1
Deguchi, R1
Takashimizu, S1
Ogasawara, F1
Numata, M1
Ohtani, Y1
Sato, S1
Mine, T1
Iwata, Y1
Masubuchi, M1
Matsumura, T1
Oomoto, K1
Horiba, T1
Sato, E1
Orihara, A1
Sonoda, H1
Hamada, J1
Itokawa, Y1
Ueshima, Y1
Takashina, K1
Lee, C1
Kuwabara, H1
Mikayama, Y1
Kitasato, Y1
Yasunaga, M1
Nakayama, M2
Akasu, G1
Yoshitomi, M1
Mikagi, K1
Kawahara, R1
Hisaka, T1
Horiuchi, H1
Kinoshita, H1
Okabe, Y1
Narita, T1
Suzuki, A2
Hashizume, E1
Yajima, M1
Mizota, A1
Matsuo, K1
Sato, Y1
Kondo, C1
Ura, T1
Tajika, M1
Okumura, K1
Shiogai, Y1
Kodama, M1
Mekata, E1
Tan, T1
Enomoto, K1
Takayama, T1
Ohno, T1
Horiguchi, N1
Asukai, K1
Miura, A1
Koguchi, H1
Matsunaga, S1
Togawa, S1
Hasegawa, I1
Sakakibara, K1
Oneyama, M1
Sekikawa, K1
Kitamura, M1
Kawahara, Y1
Ohta, R1
Hirata, Y1
Shimoda, Y1
Kawakubo, K1
Iwakura, S1
Shimamoto, T1
Higashiguchi, T1
Nakase, T1
Kunimoto, H1
Aoki, Y1
Peng, YF1
Itoh, T1
Nishikawa, M1
Satou, T1
Inoue, K1
Imamoto, H2
Takeyama, Y1
Okuno, K1
Shiozaki, H1
Shimoyama, S1
Kiyokawa, T1
Nishida, M1
Seto, Y1
Chen, Y1
Feng, Y1
Muguruma, K1
Tanaka, H1
Sakurai, K1
Kimura, K1
Nagahara, H1
Amano, R1
Noda, E1
Maeda, K1
Sawada, T3
Ohira, M4
Hirakawa, K5
Ohwada, Y1
Wang, X1
Wang, ML1
Zhou, LY1
Lu, XY1
Yang, JF1
Yu, HG1
Iizuka, R1
Kakihara, N1
Matsumura, H1
Takenaka, A1
Imazu, H1
Ochiai, M1
Sakurai, Y1
Matsubara, T1
Nozoe, Y1
Monden, M4
Ito, K1
Akiyama, S1
Nakao, A1
Tatematsu, M1
Baba, H1
Endo, K1
Ikeda, Y1
Toh, Y1
Kohnoe, S1
Okamura, T1
Nagashima, F1
Muto, M2
Sano, Y1
Mera, K1
Yano, T2
Doi, T2
Yoshida, S3
Konishi, K2
Kobayashi, O3
Sairenji, M2
Motohashi, H2
Usuki, H2
Ishimura, K1
Yachida, S2
Hagiike, M2
Okano, K1
Izuishi, K2
Karasawa, Y2
Maeta, H2
Tsujitani, S2
Kaibara, N1
Fujiwara, H2
Takagane, A1
Abe, K1
Irinoda, T1
Nakaya, T1
Yonezawa, H1
Kanzaki, N1
Ohtani, S2
Nemoto, T1
Hoshino, Y1
Kogure, M1
Naka, Y1
Fujikawa, M1
Fujii, M1
Emoto, T1
Komaki, T1
Adachi, I1
Kamei, A1
Hokita, S1
Takatori, H1
Ishigami, S1
Miyazono, F1
Arima, H1
Natsugoe, S1
Takao, S1
Aikou, T1
Hamada, N1
Nakagawa, A1
Ichiki, M1
Sai, K1
Sugawara, H1
Wada, H1
Kozuma, Y1
Kittaka, N2
Kim, T1
Takiuchi, D4
Aihara, T3
Fukunaga, M2
Ozato, H1
Tomita, N4
Kitamura, Y1
Hayashi, K3
Sasagawa, T1
Oguma, H1
Takasaki, K1
Shima, Y1
Horimi, T1
Nishioka, Y1
Okabayashi, T1
Hamada, M1
Ishikawa, T3
Shibuya, Y1
Sakurama, K1
Nishie, M1
Iwata, J1
Arai, W1
Hosoya, Y1
Saito, S1
Hirashima, Y2
Hyodo, M1
Yasuda, Y1
Nagai, H1
Shirasaka, T1
Takashima, T2
Yamagata, S2
Fukunaga, S1
Yashiro, M2
Nakata, B3
Taguchi, S1
Osugi, H1
Takemura, M1
Lee, S1
Nishizawa, S1
Iwasaki, H1
Mikata, S1
Higaki, J1
Yoshikawa, S1
Ide, H1
Kim, H1
Oimatsu, N1
Inayama, M1
Kamiike, W1
Souma, I1
Hayashi, N1
Izawa, H1
Sakita, I1
Hasuike, Y1
Fujimoto, T1
Yamada, K1
Sugiyama, Y1
Seino, K1
Kobori, H1
Maruyama, M1
Shibata, S1
Kawasaki, H1
Sasaki, M1
Kuriyama, H1
Nonaka, T1
Sawatari, T1
Tsuboi, H1
Akanuma, M1
Hata, Y1
Fujita, S1
Ooka, M1
Okajima, S1
Tsuboi, Y1
Akamoto, S1
Okada, S1
Hamai, Y1
Ukon, K1
Toge, T1
Komoto, M1
Nomura, S1
Kubota, T2
Akatsu, Y1
Yoshida, M2
Otani, Y2
Kumai, K2
Koufuji, K1
Aoyagi, K1
Yano, S1
Murakami, N1
Miyagi, M1
Imaizumi, T1
Shirouzu, K1
Seshimo, A1
Mitsuhashi, M1
Aratake, K1
Ogawa, S1
Itabashi, M1
Shirotani, N1
Kameoka, S1
Ishihara, C1
Noguchi, Y1
Ando, K1
Shotsu, M1
Ishiwa, N1
Takeda, A1
Ogoshi, T1
Endou, Y1
Tochiori, S1
Bando, E1
Kawamura, T1
Shimada, T1
Miyamoto, K1
Tanaka, M1
Kanda, T1
Banba, T1
Tanabe, T1
Kosugi, S1
Hatakeyama, K1
Takemoto, H1
Ooshiro, R1
Fujishima, M1
Tanaka, J1
Kondo, M3
Kishimoto, T1
Nakayama, T1
Masutani, S1
Tatsuta, M1
Kawasaki, T1
Koshikawa, K1
Kiriyama, K1
Wada, M1
Taniguchi, K1
Suenaga, H1
Kanazawa, S1
Seo, A1
Tokura, N1
Honda, R1
Kase, H1
Teramoto, T1
Tendo, M1
Nakazawa, K1
Yamada, N1
Aiko, S1
Yoshizumi, Y1
Sugiura, Y1
Ishizuka, T1
Sakano, T1
Kumano, I1
Maehara, T1
Kim, C2
Ohzato, H2
Koyama, F1
Kitajima, K1
Sugi, S1
Kagawa, K1
Kumamoto, T1
Murakami, K1
Fujioka, T1
Yamada, R1
Hatori, S1
Kunisaki, C1
Kanamaru, T1
Ishizone, S1
Maruta, F1
Koide, N1
Sugiyama, A2
Nakayama, J1
Miyagawa, S1
Munakata, M1
Sakata, Y1
Ishii, E1
Wada, R1
Nishiura, H1
Ishii, K1
Nonami, M1
Shigemori, M1
Katsurada, A1
Azechi, H1
Tojo, M1
Asagoe, K1
Inoue, F1
Suwa, H1
Saiga, T1
Hara, A1
Tsunemi, S1
Izumi, N1
Iwamoto, S1
Ichikawa, D1
Okamoto, K1
Sakakura, C1
Otsuji, E1
Sonoyama, T1
Hagiwara, A1
Yamagishi, H1
Sugiyama, S1
Miyade, Y1
Murakami, S1
Samejima, R1
Sumi, K1
Hidaka, K1
Uno, H1
Kayo, S1
Kawamura, C1
Mizuyama, Y1
Kaneda, K1
Nakagawa, H1
Arakawa, T1
Hosokawa, A1
Sugiyama, T1
Hattori, S1
Okuda, N1
Ichikawa, K1
Yamaoka, T1
Katou, T1
Wada, N1
Mizutani, S1
Oyama, T1
Uchikoshi, F1
Yoshidome, K1
Tori, M1
Hiraoka, K1
Yamagami, Y1
Nakahara, M1
Fukushima, N1
Nashimoto, A1
Ohta, T1
Narahara, H1
Yamaki, S1
Iwata, S1
Ohtsuka, K1
Kitaoka, A1
Masumoto, H1
Takayanagi, H1
Karaki, H1
Suzuki, H1
Yamamori, H1
Sugano, I1
Matsuyama, A1
Kameyama, T1
Okamoto, M1
Okazaki, J1
Utsunomiya, T1
Tsutsui, S1
Iwahashi, M1
Tani, M1
Sakaguchi, S1
Ueda, K1
Ichiro, M1
Nishino, E1
Tanimura, H1
Inaba, Y1
Watabe, S1
Ohe, S1
Kamio, Y1
Koyama, M1
Chiba, M1
Kanari, M1
Morikawa, A1
Okabe, R1
Miyazawa, K1
Iijima, S1
Ozaki, K1
Koyama, Y1

Clinical Trials (11)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
A Phase I/II, Single-center, Single-arm, Open-label Study of Nanoparticle Albumin-bound-paclitaxel (Nab-PTX) Plus S-1 and Sintilimab as Adjuvant Therapy in Patients With Stage IIIC Gastric Cancer[NCT04781413]Phase 1/Phase 238 participants (Anticipated)Interventional2021-03-01Recruiting
Docetaxel, Oxaliplatin, Fluorouracil (FLOT Regimen) Combined With Teriprizumab (PD-1) in the First-line Treatment of Patients With Advanced Gastric Cancer and Peritoneal Metastasis: an Open, One-arm, Exploratory Study[NCT04886193]20 participants (Anticipated)Interventional2021-04-16Recruiting
The Exploratory Study of Conversion Surgery for Apatinib in Combination With Oxaliplatin/S-1(SOX) for Patients With Unresectable Gastric Cancer[NCT03007446]Phase 220 participants (Anticipated)Interventional2016-11-30Recruiting
Comparison of Efficacy and Tolerance Between Combination Therapy and Monotherapy as a First Line Chemotherapy in Elderly Patient With Advanced Gastric Cancer; Multicenter Randomized Phase 3 Study[NCT02114359]Phase 3111 participants (Actual)Interventional2014-02-28Completed
Phase III Study of Adjuvant Capecitabine vs Observation Alone in Curatively Resected Stage IB (by AJCC 6th Edition) Gastric Cancer(KCSG ST14-05)[NCT01917552]Phase 3870 participants (Anticipated)Interventional2013-08-19Recruiting
Randomized Open-label Trial of Dose Dense, Fixed Dose Capecitabine Compared to Standard Dose Capecitabine in Metastatic Breast Cancer and Advanced/Metastatic Gastrointestinal Cancers.[NCT02595320]Phase 2200 participants (Actual)Interventional2015-10-05Active, not recruiting
Phase III Trial of S-1 and Cisplatin (3 Weekly) Versus S-1 and Oxaliplatin Combination Chemotherapy for First Line Treatment of Advanced Gastric Cancer[NCT01671449]Phase 3338 participants (Actual)Interventional2012-12-31Completed
Phase 1 Study of Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC) and Electrostatic PIPAC (ePIPAC) With Paclitaxel for Peritoneal Carcinomatosis - PIPAC2 Study[NCT05395910]Phase 136 participants (Anticipated)Interventional2022-10-31Recruiting
Phase 1 Study of Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) With Oxaliplatin. Phase 1 Study of Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) With Oxaliplatin and in Combination With Nivolumab in Patients With Peritoneal Carcinomat[NCT03172416]Phase 121 participants (Anticipated)Interventional2017-04-12Recruiting
Feasibility Study of Intraperitoneal Paclitaxel With Oxaliplatin and Capecitabine in Patients With Advanced Gastric Cancer[NCT01739894]Phase 220 participants (Anticipated)Interventional2013-01-31Recruiting
A Phase II Study of Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Combined With Sintilimab in Gastric Cancer With Peritoneal Metastasis[NCT05648487]Phase 246 participants (Anticipated)Interventional2023-01-01Not yet recruiting
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Reviews

13 reviews available for oxonic acid and Peritoneal Carcinomatosis

ArticleYear
[A Case of Remnant Gastric Cancer That Completely Responded to Neoadjuvant S-1 and Cisplatin Therapy].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2017, Volume: 44, Issue:12

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Combinations; Gastrectomy; Hum

2017
[A Case of QOL Improvement after Intestinal Stenosis Due to Peritoneal Dissemination of Gastric Cancer in Elderly Patients].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2017, Volume: 44, Issue:12

    Topics: Aged, 80 and over; Antimetabolites, Antineoplastic; Combined Modality Therapy; Drug Combinations; Fe

2017
[Curative resection of a case of advanced gastric cancer with peritoneal dissemination responding well to combination chemotherapy of docetaxel,cisplatin and S-1].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2013, Volume: 40, Issue:9

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Docetaxe

2013
[A case of jejnal cancer who was controlled peritoneal metastasis, successfully by combination therapy with docetaxel and S-1].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2013, Volume: 40, Issue:12

    Topics: Antineoplastic Combined Chemotherapy Protocols; Docetaxel; Drug Combinations; Humans; Jejunal Neopla

2013
[A case of effective treatment with S-1/gemcitabine chemotherapy and resection for advanced pancreatic cancer with peritoneal dissemination].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2014, Volume: 41, Issue:5

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Deoxycytidine; Drug

2014
[A case of highly advanced gastric cancer with peritoneal dissemination -- a histological CR to S-1 and CDDP combination chemotherapy].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2015, Volume: 42, Issue:3

    Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Combinations; Humans; Male; Middle A

2015
Gemcitabine plus S-1: a hopeful frontline treatment for Asian patients with unresectable advanced pancreatic cancer.
    Japanese journal of clinical oncology, 2015, Volume: 45, Issue:12

    Topics: Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Asian

2015
[Long-Term Disease-Free Survival through Postoperative Chemotherapy in a Case of Gastric Cancer with Peritoneal Dissemination].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2015, Volume: 42, Issue:12

    Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Doceta

2015
A comprehensive treatment for peritoneal metastases from gastric cancer with curative intent.
    European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology, 2016, Volume: 42, Issue:8

    Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cytoreduction Surgical Procedures; Doceta

2016
The Importance of Extensive Intraoperative Peritoneal Lavage as a Promising Method in Patients with Gastric Cancer Showing Positive Peritoneal Cytology Without Overt Peritoneal Metastasis and Other Therapeutic Approaches.
    Journal of investigative surgery : the official journal of the Academy of Surgical Research, 2017, Volume: 30, Issue:5

    Topics: Antimetabolites, Antineoplastic; Drug Combinations; Humans; Infusions, Parenteral; Intraoperative Ca

2017
Aggressive recurrence of gastric cancer as a granulocyte-colony-stimulating factor-producing tumor.
    International journal of clinical oncology, 2010, Volume: 15, Issue:2

    Topics: Adenocarcinoma; Antimetabolites, Antineoplastic; Biopsy; Chemotherapy, Adjuvant; Drug Combinations;

2010
[A case of scirrhous gastric carcinoma with peritoneal dissemination which was treated by curative gastrectomy after S-1/CDDP chemotherapy].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2010, Volume: 37, Issue:8

    Topics: Adenocarcinoma, Scirrhous; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Combinati

2010
[A case of peritoneal dissemination that exhibited a complete response to systemic chemotherapy following the resection of primary colon cancer].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2012, Volume: 39, Issue:12

    Topics: Antineoplastic Combined Chemotherapy Protocols; Colonic Neoplasms; Colostomy; Combined Modality Ther

2012

Trials

37 trials available for oxonic acid and Peritoneal Carcinomatosis

ArticleYear
Addition of sintilimab to nanoparticle albumin-bound paclitaxel and S-1 as adjuvant therapy in stage IIIC gastric cancer.
    Future oncology (London, England), 2022, Volume: 18, Issue:2

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Albumins; Antibodies, Monoclonal, Humanized; Antineoplas

2022
Phase I Study of Intraperitoneal Administration of Paclitaxel Combined with S-1 Plus Cisplatin for Gastric Cancer with Peritoneal Metastasis.
    Oncology, 2020, Volume: 98, Issue:1

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Combinations; Female; H

2020
Phase 1 Study of Combined Chemotherapy of Nab-Paclitaxel, S-1, and Oxaliplatin for Gastric Cancer with Peritoneal Metastasis (NSOX Study).
    Oncology, 2021, Volume: 99, Issue:1

    Topics: Aged; Albumins; Antineoplastic Combined Chemotherapy Protocols; Dose-Response Relationship, Drug; Dr

2021
The survival and prognosticators of peritoneal cytology-positive gastric cancer patients who received upfront gastrectomy and subsequent S-1 chemotherapy.
    International journal of clinical oncology, 2017, Volume: 22, Issue:5

    Topics: Aged; Disease-Free Survival; Drug Combinations; Female; Gastrectomy; Humans; Lymphatic Metastasis; M

2017
Retrospective comparison of S-1 plus cisplatin versus S-1 monotherapy for the treatment of advanced gastric cancer patients with positive peritoneal cytology but without gross peritoneal metastasis.
    International journal of clinical oncology, 2017, Volume: 22, Issue:6

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Disease-Free Survival; Drug Combina

2017
Intraperitoneal and Systemic Chemotherapy for Patients with Gastric Cancer with Peritoneal Metastasis: A Phase II Trial.
    Anticancer research, 2018, Volume: 38, Issue:10

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Female; Follow-Up Studies; H

2018
A phase II trial of gemcitabine, S-1 and LV combination (GSL) therapy in patients with advanced pancreatic cancer.
    Investigational new drugs, 2019, Volume: 37, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Drug

2019
Randomized phase III trial of gastrectomy with or without neoadjuvant S-1 plus cisplatin for type 4 or large type 3 gastric cancer, the short-term safety and surgical results: Japan Clinical Oncology Group Study (JCOG0501).
    Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, 2019, Volume: 22, Issue:5

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; D

2019
Phase I/II study of intraperitoneal docetaxel plus S-1 for the gastric cancer patients with peritoneal carcinomatosis.
    Cancer chemotherapy and pharmacology, 2013, Volume: 71, Issue:5

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Docetaxel; Dose-Response Relationship,

2013
A phase 2 trial of intravenous and intraperitoneal paclitaxel combined with S-1 for treatment of gastric cancer with macroscopic peritoneal metastasis.
    Cancer, 2013, Sep-15, Volume: 119, Issue:18

    Topics: Administration, Intravenous; Adult; Aged; Antineoplastic Agents, Phytogenic; Antineoplastic Combined

2013
Low creatinine clearance is a risk factor for D2 gastrectomy after neoadjuvant chemotherapy.
    Annals of surgical oncology, 2014, Volume: 21, Issue:9

    Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Mod

2014
Randomized phase II study of second-line chemotherapy with the best available 5-fluorouracil regimen versus weekly administration of paclitaxel in far advanced gastric cancer with severe peritoneal metastases refractory to 5-fluorouracil-containing regime
    Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, 2016, Volume: 19, Issue:3

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Capecitabine; Drug Combin

2016
Efficacy and safety of S-1 and oxaliplatin combination therapy in elderly patients with advanced gastric cancer.
    Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, 2016, Volume: 19, Issue:3

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Combinations; Female; F

2016
Multicenter Phase II Study of Intravenous and Intraperitoneal Paclitaxel With S-1 for Pancreatic Ductal Adenocarcinoma Patients With Peritoneal Metastasis.
    Annals of surgery, 2017, Volume: 265, Issue:2

    Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Pancr

2017
A randomised multicentre phase II trial of capecitabine vs S-1 as first-line treatment in elderly patients with metastatic or recurrent unresectable gastric cancer.
    British journal of cancer, 2008, Aug-19, Volume: 99, Issue:4

    Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Bone Neoplasms; Capecitabi

2008
A randomised multicentre phase II trial of capecitabine vs S-1 as first-line treatment in elderly patients with metastatic or recurrent unresectable gastric cancer.
    British journal of cancer, 2008, Aug-19, Volume: 99, Issue:4

    Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Bone Neoplasms; Capecitabi

2008
A randomised multicentre phase II trial of capecitabine vs S-1 as first-line treatment in elderly patients with metastatic or recurrent unresectable gastric cancer.
    British journal of cancer, 2008, Aug-19, Volume: 99, Issue:4

    Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Bone Neoplasms; Capecitabi

2008
A randomised multicentre phase II trial of capecitabine vs S-1 as first-line treatment in elderly patients with metastatic or recurrent unresectable gastric cancer.
    British journal of cancer, 2008, Aug-19, Volume: 99, Issue:4

    Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Bone Neoplasms; Capecitabi

2008
A randomised multicentre phase II trial of capecitabine vs S-1 as first-line treatment in elderly patients with metastatic or recurrent unresectable gastric cancer.
    British journal of cancer, 2008, Aug-19, Volume: 99, Issue:4

    Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Bone Neoplasms; Capecitabi

2008
A randomised multicentre phase II trial of capecitabine vs S-1 as first-line treatment in elderly patients with metastatic or recurrent unresectable gastric cancer.
    British journal of cancer, 2008, Aug-19, Volume: 99, Issue:4

    Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Bone Neoplasms; Capecitabi

2008
A randomised multicentre phase II trial of capecitabine vs S-1 as first-line treatment in elderly patients with metastatic or recurrent unresectable gastric cancer.
    British journal of cancer, 2008, Aug-19, Volume: 99, Issue:4

    Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Bone Neoplasms; Capecitabi

2008
A randomised multicentre phase II trial of capecitabine vs S-1 as first-line treatment in elderly patients with metastatic or recurrent unresectable gastric cancer.
    British journal of cancer, 2008, Aug-19, Volume: 99, Issue:4

    Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Bone Neoplasms; Capecitabi

2008
A randomised multicentre phase II trial of capecitabine vs S-1 as first-line treatment in elderly patients with metastatic or recurrent unresectable gastric cancer.
    British journal of cancer, 2008, Aug-19, Volume: 99, Issue:4

    Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Bone Neoplasms; Capecitabi

2008
A randomised multicentre phase II trial of capecitabine vs S-1 as first-line treatment in elderly patients with metastatic or recurrent unresectable gastric cancer.
    British journal of cancer, 2008, Aug-19, Volume: 99, Issue:4

    Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Bone Neoplasms; Capecitabi

2008
A randomised multicentre phase II trial of capecitabine vs S-1 as first-line treatment in elderly patients with metastatic or recurrent unresectable gastric cancer.
    British journal of cancer, 2008, Aug-19, Volume: 99, Issue:4

    Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Bone Neoplasms; Capecitabi

2008
A randomised multicentre phase II trial of capecitabine vs S-1 as first-line treatment in elderly patients with metastatic or recurrent unresectable gastric cancer.
    British journal of cancer, 2008, Aug-19, Volume: 99, Issue:4

    Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Bone Neoplasms; Capecitabi

2008
A randomised multicentre phase II trial of capecitabine vs S-1 as first-line treatment in elderly patients with metastatic or recurrent unresectable gastric cancer.
    British journal of cancer, 2008, Aug-19, Volume: 99, Issue:4

    Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Bone Neoplasms; Capecitabi

2008
A randomised multicentre phase II trial of capecitabine vs S-1 as first-line treatment in elderly patients with metastatic or recurrent unresectable gastric cancer.
    British journal of cancer, 2008, Aug-19, Volume: 99, Issue:4

    Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Bone Neoplasms; Capecitabi

2008
A randomised multicentre phase II trial of capecitabine vs S-1 as first-line treatment in elderly patients with metastatic or recurrent unresectable gastric cancer.
    British journal of cancer, 2008, Aug-19, Volume: 99, Issue:4

    Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Bone Neoplasms; Capecitabi

2008
A randomised multicentre phase II trial of capecitabine vs S-1 as first-line treatment in elderly patients with metastatic or recurrent unresectable gastric cancer.
    British journal of cancer, 2008, Aug-19, Volume: 99, Issue:4

    Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Bone Neoplasms; Capecitabi

2008
[Clinical trials of neo-adjuvant chemotherapy for advanced gastric cancer with peritoneal dissemination].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2008, Volume: 35, Issue:12

    Topics: Antineoplastic Combined Chemotherapy Protocols; Docetaxel; Dose-Response Relationship, Drug; Drug Co

2008
[Treatment for advanced gastric cancer with positive lavage cytology-systemic versus intraperitoneal chemotherapy].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2008, Volume: 35, Issue:12

    Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Combinations; Female; Gastric Lavage

2008
Phase I pharmacokinetic study of weekly intravenous and intraperitoneal paclitaxel combined with S-1 for advanced gastric cancer.
    Oncology, 2009, Volume: 76, Issue:5

    Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Drug Combinations; Fema

2009
Phase II study of weekly intravenous and intraperitoneal paclitaxel combined with S-1 for advanced gastric cancer with peritoneal metastasis.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2010, Volume: 21, Issue:1

    Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Drug

2010
Phase II study of weekly intravenous and intraperitoneal paclitaxel combined with S-1 for advanced gastric cancer with peritoneal metastasis.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2010, Volume: 21, Issue:1

    Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Drug

2010
Phase II study of weekly intravenous and intraperitoneal paclitaxel combined with S-1 for advanced gastric cancer with peritoneal metastasis.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2010, Volume: 21, Issue:1

    Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Drug

2010
Phase II study of weekly intravenous and intraperitoneal paclitaxel combined with S-1 for advanced gastric cancer with peritoneal metastasis.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2010, Volume: 21, Issue:1

    Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Drug

2010
Phase II study of weekly intravenous and intraperitoneal paclitaxel combined with S-1 for advanced gastric cancer with peritoneal metastasis.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2010, Volume: 21, Issue:1

    Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Drug

2010
Phase II study of weekly intravenous and intraperitoneal paclitaxel combined with S-1 for advanced gastric cancer with peritoneal metastasis.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2010, Volume: 21, Issue:1

    Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Drug

2010
Phase II study of weekly intravenous and intraperitoneal paclitaxel combined with S-1 for advanced gastric cancer with peritoneal metastasis.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2010, Volume: 21, Issue:1

    Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Drug

2010
Phase II study of weekly intravenous and intraperitoneal paclitaxel combined with S-1 for advanced gastric cancer with peritoneal metastasis.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2010, Volume: 21, Issue:1

    Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Drug

2010
Phase II study of weekly intravenous and intraperitoneal paclitaxel combined with S-1 for advanced gastric cancer with peritoneal metastasis.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2010, Volume: 21, Issue:1

    Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Drug

2010
Phase II study of oxaliplatin plus S-1 as first-line treatment for advanced gastric cancer (G-SOX study).
    Annals of oncology : official journal of the European Society for Medical Oncology, 2010, Volume: 21, Issue:5

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Drug Combinations; Female; Follow-Up St

2010
Phase II clinical trial of postoperative S-1 monotherapy for gastric cancer patients with free intraperitoneal cancer cells detected by real-time RT-PCR.
    World journal of surgery, 2010, Volume: 34, Issue:9

    Topics: Adenocarcinoma; Antimetabolites, Antineoplastic; Carcinoembryonic Antigen; Chemotherapy, Adjuvant; D

2010
Impact of S-1 in patients with gemcitabine-refractory pancreatic cancer in Japan.
    Japanese journal of clinical oncology, 2010, Volume: 40, Issue:8

    Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Deoxycytidine; Disease-Free Surviva

2010
Feasibility study of S-1 and intraperitoneal docetaxel combination chemotherapy for gastric cancer with peritoneal dissemination.
    Anticancer research, 2010, Volume: 30, Issue:4

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Docetaxel; Dose-Response Relationship, Drug; D

2010
Phase I study of docetaxel, cisplatin and S-1 in patients with advanced gastric cancer.
    Japanese journal of clinical oncology, 2010, Volume: 40, Issue:11

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Docetaxel; Drug Combinations; Femal

2010
Intraperitoneal infusion of paclitaxel with S-1 for peritoneal metastasis of advanced gastric cancer: phase I study.
    The journal of medical investigation : JMI, 2011, Volume: 58, Issue:1-2

    Topics: Adenocarcinoma; Aged; Antineoplastic Agents, Phytogenic; Ascitic Fluid; Drug Combinations; Female; H

2011
[The updated treatment strategy for gastric cancer with peritoneal metastasis].
    Nihon Geka Gakkai zasshi, 2012, Volume: 113, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocol

2012
A preliminary study of single intraperitoneal administration of paclitaxel followed by sequential systemic chemotherapy with S-1 plus paclitaxel for advanced gastric cancer with peritoneal metastasis.
    Anticancer research, 2012, Volume: 32, Issue:9

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Drug Administration Schedule; Drug Comb

2012
Combination of low-dose docetaxel and standard-dose S-1 for the treatment of advanced gastric cancer: efficacy, toxicity, and potential predictive factor.
    Cancer chemotherapy and pharmacology, 2013, Volume: 71, Issue:1

    Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Dihydrouracil Dehydroge

2013
Randomized phase II study comparing paclitaxel with S-1 vs. S-1 as first-line treatment in patients with advanced gastric cancer.
    Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 2013, Volume: 15, Issue:10

    Topics: Adenocarcinoma; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Drug Combin

2013
Clinical efficacy of S-1 combined with cisplatin for advanced gastric cancer.
    Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, 2003, Volume: 6 Suppl 1

    Topics: Adenocarcinoma; Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy P

2003
Combination chemotherapy of S-1 and low-dose cisplatin for advanced gastric cancer.
    Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, 2003, Volume: 6 Suppl 1

    Topics: Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Cispla

2003
Prediction of sensitivity to fluoropyrimidines by metabolic and target enzyme activities in gastric cancer.
    Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, 2003, Volume: 6 Suppl 1

    Topics: Adult; Aged; Aged, 80 and over; Animals; Antimetabolites, Antineoplastic; Antineoplastic Combined Ch

2003
Pilot study of S-1 in patients with disseminated gastric cancer.
    Drugs under experimental and clinical research, 2003, Volume: 29, Issue:3

    Topics: Administration, Oral; Adult; Aged; Drug Administration Schedule; Drug Combinations; Female; Humans;

2003
[Neoadjuvant chemotherapy for gastric cancer with peritoneal dissemination].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2007, Volume: 34, Issue:12

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Docetaxel; Drug Combinations; Female; F

2007
[A multi-centric phase I/II study of intraperitoneal docetaxel combined with S-1 for patients with peritoneal dissemination of gastric cancer].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2007, Volume: 34, Issue:12

    Topics: Antineoplastic Combined Chemotherapy Protocols; Docetaxel; Drug Combinations; Humans; Infusions, Par

2007
Multi-center phase II study for combination therapy with paclitaxel/doxifluridine to treat advanced/recurrent gastric cancer showing resistance to S-1 (OGSG 0302).
    Japanese journal of clinical oncology, 2008, Volume: 38, Issue:3

    Topics: Adenocarcinoma; Aged; Anemia; Anorexia; Antineoplastic Combined Chemotherapy Protocols; Disease-Free

2008
[The clinical effect of TS-1 in advanced and recurrent gastric cancer with peritoneal dissemination].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2002, Volume: 29, Issue:2

    Topics: Adult; Aged; Antimetabolites, Antineoplastic; Drug Administration Schedule; Drug Combinations; Femal

2002

Other Studies

165 other studies available for oxonic acid and Peritoneal Carcinomatosis

ArticleYear
Postoperative Treatment of Resectable Pancreatic Cancer With Positive Peritoneal Lavage Cytology: A Multicentre Retrospective Study.
    Anticancer research, 2022, Volume: 42, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Chemotherapy, Adjuvant; Deoxycytidine; Drug Combinations; Female; Ge

2022
Efficacy of AS versus SOX regimen as first-line chemotherapy for gastric cancer patients with peritoneal metastasis: a real-world study.
    BMC gastroenterology, 2022, Jun-14, Volume: 22, Issue:1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Drug Combinations; Gastrectomy; Humans; Oxaliplatin;

2022
Efficacy of Postoperative Chemotherapy After Resection that Leaves No Macroscopically Visible Disease of Gastric Cancer with Positive Peritoneal Lavage Cytology (CY1) or Localized Peritoneum Metastasis (P1a): A Multicenter Retrospective Study.
    Annals of surgical oncology, 2020, Volume: 27, Issue:1

    Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cisp

2020
[A Long Term Survival Case of Gastric Cancer with Peritoneal Dissemination Responding to Intraperitoneal Chemotherapy].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2020, Volume: 47, Issue:8

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Drug Combinations; Female; Gastrectomy; Human

2020
[A Case of Advanced Gastric Cancer with Peritoneal Metastasis Achieved Pathological Complete Response by Chemotherapy(SOX Regimen)].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2020, Volume: 47, Issue:13

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Drug Combinations; Female; Gastrectomy; Humans

2020
Peritoneal Lavage CEA mRNA Levels Predict Conversion Gastrectomy Outcomes after Induction Chemotherapy with Intraperitoneal Paclitaxel in Gastric Cancer Patients with Peritoneal Metastasis.
    Annals of surgical oncology, 2017, Volume: 24, Issue:11

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoembryonic Antigen; Combined Moda

2017
[A Case of Unresectable Gastric Cancer with Multiple Metastases Responding to Chemotherapy].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2017, Volume: 44, Issue:12

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Combinations; Humans; Liver Ne

2017
[Advanced Gastric Cancer with Peritoneal Dissemination Treated with Conversion Surgery after S-1 and CDDP Chemotherapy - A Case Report].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2018, Volume: 45, Issue:3

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Combinations; Female; Humans;

2018
Intraperitoneal Administration of Paclitaxel Followed by Paclitaxel, Cisplatin, and S-1 Chemotherapy for Cytology-positive Gastric Cancer: A Feasibility Study.
    Anticancer research, 2018, Volume: 38, Issue:10

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Combinations; Feasibility Stud

2018
[A Case of Advanced Gastric Cancer with Peritoneal Dissemination after Gastrectomy Effectively Treated with Combination Chemotherapy of Ramucirumab and Paclitaxel].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2018, Volume: 45, Issue:13

    Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherap

2018
[Three Cases of Advanced Gastric Cancer with Peritoneal Dissemination Successfully Treated with S-1 and Docetaxel Combination Chemotherapy].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2018, Volume: 45, Issue:13

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Docetaxel; Drug Combinations; Female; Gastrect

2018
[A Case of Peritoneal Dissemination of Metastatic Gastric Cancer with Successful Docetaxel and S-1 Combination Therapy].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2018, Volume: 45, Issue:13

    Topics: Antineoplastic Combined Chemotherapy Protocols; Docetaxel; Drug Combinations; Gastrectomy; Humans; M

2018
[A Case of Robot-Assisted Conversion Surgery for Gastric Cancer with Peritoneal Dissemination That Responded to Intravenous and Intraperitoneal Paclitaxel Combined with S-1 Chemotherapy].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2019, Volume: 46, Issue:1

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Drug Combinations; Female; Gastrectomy; Humans

2019
[Multi-Look Staging Laparoscopy and Conversion Surgery for Gastric Cancer with Peritoneal Metastases].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2019, Volume: 46, Issue:1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Drug Combinations; Gastrectomy; Humans; Laparoscopy;

2019
Fluoropyrimidine with or without platinum as first-line chemotherapy in patients with advanced gastric cancer and severe peritoneal metastasis: a multicenter retrospective study.
    BMC cancer, 2019, Jul-03, Volume: 19, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Ascites; Cisplatin;

2019
Survival analysis of adjuvant chemotherapy with S-1 plus cisplatin for stage III gastric cancer.
    Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, 2014, Volume: 17, Issue:2

    Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Drug Combinations

2014
A patient with scirrhous stomach cancer treated with combination of hyperthermotherapy and 5-aminolevulinic acid (ALA).
    Anticancer research, 2013, Volume: 33, Issue:7

    Topics: Adenocarcinoma, Scirrhous; Adult; Aminolevulinic Acid; Antineoplastic Combined Chemotherapy Protocol

2013
[A case of AFP-producing gastric cancer with peritoneal metastasis treated effectively with chemotherapy, mainly using S-1 and trastuzumab].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2013, Volume: 40, Issue:4

    Topics: Aged; alpha-Fetoproteins; Antibodies, Monoclonal, Humanized; Antimetabolites, Antineoplastic; Antine

2013
[Approximately four years of survival benefits for a case of gastric cancer postoperative carcinomatous peritonitis by combined modality therapy].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2013, Volume: 40, Issue:5

    Topics: Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Cisplatin; Combined Modality Therapy;

2013
Salvage gastrectomy after intravenous and intraperitoneal paclitaxel (PTX) administration with oral S-1 for peritoneal dissemination of advanced gastric cancer with malignant ascites.
    Annals of surgical oncology, 2014, Volume: 21, Issue:2

    Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Ascites; Combined

2014
Salvage gastrectomy after intravenous and intraperitoneal paclitaxel (PTX) administration with oral S-1 for peritoneal dissemination of advanced gastric cancer with malignant ascites.
    Annals of surgical oncology, 2014, Volume: 21, Issue:2

    Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Ascites; Combined

2014
Salvage gastrectomy after intravenous and intraperitoneal paclitaxel (PTX) administration with oral S-1 for peritoneal dissemination of advanced gastric cancer with malignant ascites.
    Annals of surgical oncology, 2014, Volume: 21, Issue:2

    Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Ascites; Combined

2014
Salvage gastrectomy after intravenous and intraperitoneal paclitaxel (PTX) administration with oral S-1 for peritoneal dissemination of advanced gastric cancer with malignant ascites.
    Annals of surgical oncology, 2014, Volume: 21, Issue:2

    Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Ascites; Combined

2014
Feasibility study of oxaliplatin with oral S-1 or capecitabine as first-line therapy for patients with metastases from colorectal cancer.
    Anticancer research, 2013, Volume: 33, Issue:9

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Colorectal Neoplasms; Deoxycytid

2013
Adjuvant chemotherapy with S-1 followed by docetaxel for gastric cancer and CY1P0 peritoneal metastasis after relatively curative surgery.
    Journal of Nippon Medical School = Nippon Ika Daigaku zasshi, 2013, Volume: 80, Issue:5

    Topics: Administration, Intravenous; Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy

2013
Outcome data of patients with peritoneal carcinomatosis from gastric origin treated by a strategy of bidirectional chemotherapy prior to cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in a single specialized center in Japan.
    Annals of surgical oncology, 2014, Volume: 21, Issue:4

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Cancer, Regional Perfusio

2014
[A case of gastric cancer with intensive peritoneal dissemination treated with long-term chemotherapy and surgery].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2013, Volume: 40, Issue:12

    Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Docetaxel; Drug Combinati

2013
[A case of advanced gastric cancer with peritoneal dissemination recurrence after gastrectomy effectively treated with combination chemotherapy of S-1 and docetaxel].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2013, Volume: 40, Issue:12

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Docetaxel; Drug Combinations; Gastrectomy; Hum

2013
[A case of rectal stenosis due to peritoneal dissemination from gastric cancer that was treated with chemoradiation therapy].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2013, Volume: 40, Issue:12

    Topics: Aged, 80 and over; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Chemoradiothe

2013
[Repeated occlusion of the intraperitoneal access port for intraperitoneal chemotherapy in a patient with gastric cancer with peritoneal dissemination].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2013, Volume: 40, Issue:12

    Topics: Antineoplastic Combined Chemotherapy Protocols; Drug Combinations; Humans; Male; Middle Aged; Oxonic

2013
Usefulness of monthly chemotherapy for patients with unresectable metastatic colorectal cancer.
    Anticancer research, 2014, Volume: 34, Issue:1

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Colorectal Neoplasms; Deoxycytid

2014
[A case of unresected gastric cancer that maintained long tumor dormancy by use of paclitaxel+S-1 combination therapy].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2014, Volume: 41, Issue:2

    Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Drug Combinations; Female; Humans; M

2014
Clinical evaluation of cetuximab combined with an S-1 and oxaliplatin regimen for Chinese patients with advanced gastric cancer.
    World journal of surgical oncology, 2014, Apr-23, Volume: 12

    Topics: Adult; Aged; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Cetu

2014
[A case of a patient with gastric cancer and peritoneal dissemination who survived for more than 10 years after successful treatment with S-1].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2014, Volume: 41, Issue:6

    Topics: Antimetabolites, Antineoplastic; Combined Modality Therapy; Drug Combinations; Female; Gastrectomy;

2014
[A case of gastric adenosquamous carcinoma with peritoneal dissemination in which treatment with S-1 plus paclitaxel therapy resulted in improved long-term survival].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2014, Volume: 41, Issue:7

    Topics: Antineoplastic Combined Chemotherapy Protocols; Biopsy; Carcinoma, Adenosquamous; Chemotherapy, Adju

2014
Clinical significance of cytological status of peritoneal lavage fluid during intraperitoneal chemotherapy for gastric cancer with overt peritoneal dissemination.
    Annals of surgical oncology, 2015, Volume: 22, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Th

2015
[A case of gastric cancer with peritoneal dissemination successfully treated with low-dose S-1 or capecitabine chemotherapy for five years].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2014, Volume: 41, Issue:9

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Deoxycytidine; Drug Combinations

2014
[Long-term disease-free survival by S-1 therapy in a case of gastric cancer with peritoneal dissemination].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2014, Volume: 41, Issue:11

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Disease-Free Surviv

2014
[A case of intrahepatic cholangiocarcinoma with peritoneal dissemination treated successfully with surgical resection and adjuvant chemotherapy].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2014, Volume: 41, Issue:12

    Topics: Aged; Antimetabolites, Antineoplastic; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Chemotherapy,

2014
[A case of radical resection for pancreatic head cancer with peritoneal dissemination treated with combination chemotherapy].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2014, Volume: 41, Issue:12

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Drug Combinations; Gemcitabine;

2014
[A case of advanced gastric cancer successfully treated with second-line chemotherapy followed by curative conversion gastrectomy].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2014, Volume: 41, Issue:12

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Combined Modality Therapy; Drug

2014
[A case of successful treatment of peritoneal dissemination from gastric cancer with S-1/DOC chemotherapy].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2014, Volume: 41, Issue:12

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Docetaxel; Drug Combinations; Gastrectomy; Hum

2014
[A recurrent gastric cancer with peritoneal metastasis 15 years after distal gastrectomy successfully treated with S-1 and weekly intravenous and intraperitoneal injections of Paclitaxel].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2015, Volume: 42, Issue:3

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Ascites; Drug Combinations; Female; Gastrectom

2015
Preoperative systemic and intraperitoneal chemotherapy consisting of S-1, cisplatin and docetaxel in patients with marginally resectable gastric cancer.
    Anticancer research, 2015, Volume: 35, Issue:4

    Topics: Adult; Aged; Cisplatin; Docetaxel; Drug Combinations; Drug-Related Side Effects and Adverse Reaction

2015
Cell-free and concentrated ascites reinfusion therapy (CART) for management of massive malignant ascites in gastric cancer patients with peritoneal metastasis treated with intravenous and intraperitoneal paclitaxel with oral S-1.
    European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology, 2015, Volume: 41, Issue:7

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Ascites; Ascitic Fluid; Blood Proteins;

2015
Reduced preoperative serum albumin and absence of peritoneal dissemination may be predictive factors for long-term survival with advanced gastric cancer with positive cytology test.
    European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology, 2015, Volume: 41, Issue:10

    Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cis

2015
[S-1 plus Cisplatin Combination Therapy for Gastric Cancer with Peritoneal Dissemination].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2015, Volume: 42, Issue:12

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Drug Com

2015
[A Case of Long-Term Survival of a Patient with Gastric Cancer with Peritoneal Dissemination].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2015, Volume: 42, Issue:12

    Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Drug Combinations; Gastrectomy

2015
[A Case of Double Cancers of the Stomach and Endometrium with Peritoneal Metastasis].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2015, Volume: 42, Issue:12

    Topics: Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Drug C

2015
[A Case of Advanced Gastric Cancer with Peritoneal Dissemination Effectively Treated with S-1 and Docetaxel Combination Chemotherapy].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2015, Volume: 42, Issue:12

    Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Doceta

2015
[Introduction of Chemotherapy for Advanced Gastric Cancer Showing Oncologic Emergency Caused by Peritoneal Dissemination--Report of Tow Cases].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2015, Volume: 42, Issue:12

    Topics: Antineoplastic Combined Chemotherapy Protocols; Drug Combinations; Female; Humans; Ileus; Jaundice,

2015
[A Patient with Gastric Cancer with Peritoneal Dissemination Who Survived for Five Years after Sequential Chemotherapy with S-1 Followed by Paclitaxel].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2016, Volume: 43, Issue:2

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Drug Combinations; Fat

2016
[Pathological Complete Response to SOX plus Bevacizumab for Treating Stage IV Sigmoid Colon Cancer].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2016, Volume: 43, Issue:6

    Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Constipation; Drug Comb

2016
[Outcomes of Staging Laparoscopy in Eight Patients with Positive Peritoneal Washing Cytology after S-1 Administration].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2016, Volume: 43, Issue:9

    Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Chemotherapy, Adjuvant; Drug Combin

2016
Surgery after intraperitoneal and systemic chemotherapy for gastric cancer with peritoneal metastasis or positive peritoneal cytology findings.
    Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, 2017, Volume: 20, Issue:Suppl 1

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Th

2017
[A Case of Advanced Gastric Cancer Successfully Treated with Curative Conversion Surgery after Chemotherapy with S-1 plus Oxaliplatin].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2016, Volume: 43, Issue:12

    Topics: Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Drug Combinations; Humans; Male;

2016
[A case of gastric cancer with peritoneal dissemination responding to combination chemotherapy with oral fluoropyrimidine and weekly paclitaxel].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2008, Volume: 35, Issue:6

    Topics: Administration, Oral; Adult; Antineoplastic Combined Chemotherapy Protocols; Drug Combinations; Fema

2008
[A case of Stage IV gastric cancer with liver and peritoneal metastases responding completely to tailored S-1/CPT- 11 combination therapy].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2008, Volume: 35, Issue:7

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Camptothecin; Drug Combinat

2008
[A case of peritoneal disseminated sigmoid colon cancer with liver metastasis responding to S-1].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2008, Volume: 35, Issue:7

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Drug Combinations; Humans;

2008
Pathological complete response induced by the combination therapy of S-1 and 24-h infusion of cisplatin in two cases initially diagnosed as inoperable advanced gastric cancer.
    Oncology reports, 2008, Volume: 20, Issue:2

    Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bone

2008
[A case of scirrhous gastric cancer with peritoneal dissemination acquiring stable disease over three years by treatment with oral anticancer drug S-1].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2008, Volume: 35, Issue:8

    Topics: Adenocarcinoma, Scirrhous; Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocol

2008
Pilot study of intraperitoneal administration of paclitaxel and oral S-1 for patients with peritoneal metastasis due to advanced gastric cancer.
    International journal of clinical oncology, 2008, Volume: 13, Issue:6

    Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Drug Combinations; Fema

2008
[A case of perforated gastric cancer in which resection for elimination was possible S-1/CDDP combined chemotherapy for peritonitis carcinomatosa].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2009, Volume: 36, Issue:1

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Combinations; Gastroscopy; Hum

2009
[Two advanced gastric cancer cases with peritoneal metastases successfully treated by s-1/paclitaxel combination therapy].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2009, Volume: 36, Issue:6

    Topics: Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Ch

2009
[A resected case of effective treatment with S-1/gemcitabine and Paclitaxel combination chemotherapy for advanced pancreatic cancer with peritoneal and liver metastases].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2009, Volume: 36, Issue:7

    Topics: Adenocarcinoma; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic C

2009
Octreotide acetate successfully treated a bowel obstruction caused by peritoneally disseminated gastric cancer, thereby enabling the subsequent use of oral S-1 chemotherapy.
    International journal of clinical oncology, 2009, Volume: 14, Issue:4

    Topics: Adenocarcinoma; Administration, Oral; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined

2009
[A case of gastric cancer with peritoneal dissemination-efficacy of combination therapy with S-1 and docetaxel].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2009, Volume: 36, Issue:9

    Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protoco

2009
Induction chemotherapy with S-1 plus cisplatin followed by surgery for treatment of gastric cancer with peritoneal dissemination.
    Annals of surgical oncology, 2009, Volume: 16, Issue:12

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Comb

2009
[A case of gastric cancer with peritoneal dissemination who achieved long survival by successive treatments with S-1 in combination with CDDP, paclitaxel and irinotecan].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2009, Volume: 36, Issue:10

    Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Cisplatin; Drug

2009
[Outcome of therapy for type 4 gastric cancer with peritoneal metastasis--diagnosis by laparoscopy and effect of chemotherapy].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2009, Volume: 36, Issue:12

    Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemothe

2009
[A case of gastric cancer with peritoneal dissemination which has been alive more than three years responding to intraperitoneal chemotherapy].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2009, Volume: 36, Issue:12

    Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineopl

2009
[A case of far-advanced gastric cancer with peritoneal dissemination and obstructive jaundice effectively treated with combination chemotherapy and interventional radiology].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2009, Volume: 36, Issue:12

    Topics: Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy P

2009
[A partial response to S-1 as second-line chemotherapy in a patient with unresectable pancreatic cancer].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2009, Volume: 36, Issue:12

    Topics: Administration, Oral; Antimetabolites, Antineoplastic; Deoxycytidine; Drug Combinations; Gemcitabine

2009
[Two cases of advanced gastric cancer with peritoneal dissemination, and Virchow's metastases successfully treated by combination therapy of S-1 and docetaxel].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2010, Volume: 37, Issue:1

    Topics: Adult; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy

2010
[Combination of S-1 and paclitaxel for advanced/recurrent gastric cancer patients with peritoneal metastasis, feasibility study (OGSG0401)].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2010, Volume: 37, Issue:1

    Topics: Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Ch

2010
[A case of type 4 gastric cancer with peritoneal dissemination complicating venous thromboembolism treated effectively by combination of S-1 and warfarin].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2010, Volume: 37, Issue:2

    Topics: Antineoplastic Combined Chemotherapy Protocols; Biopsy; Combined Modality Therapy; Drug Combinations

2010
Weekly intravenous and intraperitoneal paclitaxel combined with S-1 for malignant ascites due to advanced gastric cancer.
    Oncology, 2010, Volume: 78, Issue:1

    Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Ascites; Drug Adm

2010
[Strategy of treatment for gastric cancer with peritoneal metastasis].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2010, Volume: 37, Issue:3

    Topics: Aged; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Drug Combin

2010
Pilot study of a combination of S-1 and paclitaxel for patients with peritoneal metastasis from gastric cancer.
    Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, 2010, Volume: 13, Issue:2

    Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Drug Combinations; Female; Hum

2010
[S-1-based chemotherapy for recurrent gastric cancer with peritoneal dissemination resulting in long-term survival--report of a case].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2010, Volume: 37, Issue:7

    Topics: Antimetabolites, Antineoplastic; Drug Combinations; Fatal Outcome; Humans; Male; Middle Aged; Oxonic

2010
[A very elderly case of recurrent gastric cancer with peritoneal dissemination effectively treated by combination chemotherapy of docetaxel (DOC) and S-1].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2010, Volume: 37, Issue:8

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Docetaxel; Drug Com

2010
[Pharmacokinetic study of S-1 for the treatment of peritoneal metastasis from colon cancer--using a mouse peritoneal metastasis model].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2010, Volume: 37, Issue:9

    Topics: Administration, Oral; Animals; Cell Line, Tumor; Colonic Neoplasms; Disease Models, Animal; Drug Com

2010
[The effects of gastrojejunostomy for patients with advanced gastric cancer accompanied by peritoneal dissemination].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2010, Volume: 37, Issue:12

    Topics: Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Drug Combinations; Female; Gastric Bypass;

2010
[An effective treatment by chemotherapy with S-1 and CDDP intraperitoneal administration for the peritoneal dissemination of gastric cancer--a case report].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2010, Volume: 37, Issue:12

    Topics: Adenocarcinoma; Administration, Oral; Adult; Antimetabolites, Antineoplastic; Antineoplastic Agents;

2010
[A case of gastric cancer with peritoneal dissemination successfully treated by S-1/paclitaxel combination chemotherapy].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2011, Volume: 38, Issue:2

    Topics: Antineoplastic Combined Chemotherapy Protocols; Drug Combinations; Female; Gastroscopy; Humans; Midd

2011
A case of progressive digital ischemia after early withdrawal of gemcitabine and S-1 in a patient with systemic sclerosis.
    Japanese journal of clinical oncology, 2011, Volume: 41, Issue:6

    Topics: Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine

2011
Good response chemotherapy for late-recurring gastric cancer in the gluteals, with peritoneal and retroperitoneal dissemination.
    The Tokai journal of experimental and clinical medicine, 2011, Apr-20, Volume: 36, Issue:1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Buttocks; Carcinoma, Signet Ring Cell; Cisplatin; Dr

2011
[A case of gastric carcinoma with peritoneal metastasis successfully treated by combination chemotherapy of S-1 and cisplatin].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2011, Volume: 38, Issue:5

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Cisplatin; Combined Modality Therapy;

2011
[Primary adenocarcinoma of small intestine with peritoneal dissemination treated with S-1 and CPT-11 combination chemotherapy].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2011, Volume: 38, Issue:6

    Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Combined Modality Ther

2011
[A case of unresectable advanced gastric cancer treated with S-1/low-dose CDDP combination chemotherapy through jejunostomy].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2011, Volume: 38, Issue:7

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Drug Com

2011
Intraperitoneal docetaxel combined with S-1 for advanced gastric cancer with peritoneal dissemination.
    Journal of surgical oncology, 2012, Volume: 105, Issue:1

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Combined Modality Ther

2012
Risk factors for peritoneal recurrence in stage II/III gastric cancer patients who received S-1 adjuvant chemotherapy after D2 gastrectomy.
    Annals of surgical oncology, 2012, Volume: 19, Issue:5

    Topics: Adult; Aged; Antimetabolites, Antineoplastic; Chemotherapy, Adjuvant; Disease-Free Survival; Drug Co

2012
[A case report of the combination therapy with S-1 plus CDDP intraperitoneal chemotherapy for CY positive cancer patient].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2011, Volume: 38, Issue:12

    Topics: Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Combinations;

2011
[A case of peritoneal recurrence of invasive carcinoma derived from IPMN after distal pancreatectomy].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2011, Volume: 38, Issue:12

    Topics: Antineoplastic Agents; Carcinoma, Pancreatic Ductal; Chemoradiotherapy; Deoxycytidine; Drug Combinat

2011
[Peritoneal lavage cytology under local anesthesia for detection of peritoneal recurrence after surgery].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2011, Volume: 38, Issue:12

    Topics: Aged; Anesthesia, Local; Antineoplastic Combined Chemotherapy Protocols; Docetaxel; Drug Combination

2011
[A case of advanced gastric cancer with peritoneal dissemination successfully treated with S-1 and intraperitoneal docetaxel administration].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2012, Volume: 39, Issue:1

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Combined Modality Therapy; Docetaxel;

2012
Fluoropyrimidine plus cisplatin for patients with advanced or recurrent gastric cancer with peritoneal metastasis.
    Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, 2013, Volume: 16, Issue:1

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Ascites; Capecitabine; Cisplatin; Deoxy

2013
[Two cases of advanced gastric cancer with peritonitis carcinomatosa that showed disappearance of ascites and obtained a good quality of life by using DIF and paclitaxel].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2012, Volume: 39, Issue:4

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Ascites; Dihydrouracil Dehydrogenase (NADP); D

2012
[A case report of advanced gastric cancer with peritoneal dissemination effectively treated by combination chemotherapy of S-1 and docetaxel].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2012, Volume: 39, Issue:6

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Docetaxel; Drug Combinations; Humans; Male; Ne

2012
[A case of gastric cancer with peritoneal dissemination who achieved long survival from control of ascites for over 2 years by successive treatments with S-1 in combination with docetaxel as first-line followed by irinotecan in combination with cisplatin
    Gan to kagaku ryoho. Cancer & chemotherapy, 2012, Volume: 39, Issue:7

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Ascites; Camptothecin; Cisplatin; Docetaxel; D

2012
[A long-surviving patient with unresectable advanced gastric cancer treated with S-1 and biweekly paclitaxel combination chemotherapy as second-line treatment].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2012, Volume: 39, Issue:7

    Topics: Antineoplastic Combined Chemotherapy Protocols; Drug Combinations; Fatal Outcome; Humans; Male; Midd

2012
Role of intervention for biliary and gastric/intestinal obstruction in gastric cancer with peritoneal metastasis.
    Journal of gastroenterology and hepatology, 2012, Volume: 27, Issue:12

    Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cholestasis; Drainage;

2012
[A case of gastric cancer with peritoneal dissemination and massive ascites successfully treated with S-1/docetaxel therapy].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2012, Volume: 39, Issue:8

    Topics: Antineoplastic Combined Chemotherapy Protocols; Ascites; Biopsy; Docetaxel; Drug Combinations; Femal

2012
[S-1 monotherapy achieved twenty-month survival for peritoneal lavage cytology-positive gastric cancer patient undergoing noncurative resection].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2012, Volume: 39, Issue:9

    Topics: Aged, 80 and over; Antimetabolites, Antineoplastic; Combined Modality Therapy; Drug Combinations; Ga

2012
[A case of far-advanced gastric cancer successfully treated with S-1/paclitaxel/krestin immunochemotherapy, followed by curative resection].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2012, Volume: 39, Issue:12

    Topics: Antineoplastic Combined Chemotherapy Protocols; Drug Combinations; Female; Humans; Immunotherapy; Li

2012
[Concentration of FT and CDHP and 5-FU in the ascites fluid of patient with peritoneal carcinomatosis after new anti-cancer drug TS-1 oral administration].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2002, Volume: 29, Issue:7

    Topics: Adenocarcinoma; Administration, Oral; Antimetabolites, Antineoplastic; Ascitic Fluid; Drug Combinati

2002
[A surgically resected case of advanced gastric carcinoma with peritoneal dissemination after treatment with combined chemotherapy of TS-1 and CDDP].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2003, Volume: 30, Issue:1

    Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Administration Sched

2003
Prevention of peritoneal metastasis of human gastric cancer cells in nude mice by S-1, a novel oral derivative of 5-Fluorouracil.
    Oncology, 2003, Volume: 64, Issue:2

    Topics: Administration, Oral; Animals; Antimetabolites, Antineoplastic; Disease Models, Animal; Drug Combina

2003
Chemosensitivity of peritoneal micrometastases as evaluated using a green fluorescence protein (GFP)-tagged human gastric cancer cell line.
    Cancer science, 2003, Volume: 94, Issue:1

    Topics: Administration, Oral; Animals; Antimetabolites, Antineoplastic; Ascites; Carcinoma; Cell Count; Dose

2003
Experimental study to evaluate the usefulness of S-1 in a model of peritoneal dissemination of gastric cancer.
    Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, 2003, Volume: 6 Suppl 1

    Topics: Animals; Antimetabolites, Antineoplastic; Body Weight; Disease Models, Animal; Drug Combinations; Ea

2003
Efficacy and safety profile of S-1 in patients with metastatic gastric cancer in clinical practice: results from a post-marketing survey.
    Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, 2003, Volume: 6 Suppl 1

    Topics: Adenocarcinoma; Adult; Aged; Antimetabolites, Antineoplastic; Drug Combinations; Drug Evaluation; Fe

2003
Longterm control of advanced and recurrent gastric cancer (ARGC) by S-1.
    Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, 2003, Volume: 6 Suppl 1

    Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Dose-Response Relationship, Drug; D

2003
Dihydropyrimidine dehydrogenase (DPD) activity in gastric cancer tissue and effect of DPD inhibitory fluoropyrimidines.
    Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, 2003, Volume: 6 Suppl 1

    Topics: Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Dihydrouracil Dehyd

2003
[A case of peritoneal metastasis of gastric cancer responding to TS-1, administered for four consecutive weeks with two-week rests].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2003, Volume: 30, Issue:6

    Topics: Adenocarcinoma; Administration, Oral; Antimetabolites, Antineoplastic; Drug Combinations; Humans; Ma

2003
[A case of advanced type 4 gastric cancer with peritonitis dissemination, navel metastasis effectively treated with combined chemotherapy of biweekly paclitaxel (TXL) and TS-1].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2003, Volume: 30, Issue:9

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Colectomy; Colonic Di

2003
[Efficacy of TS-1 in patients with peritonitis carcinomatosa from gastric cancer].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2003, Volume: 30, Issue:10

    Topics: Adult; Aged; Antimetabolites, Antineoplastic; Combined Modality Therapy; Drug Administration Schedul

2003
[A case of gastric cancer with peritoneal dissemination which showed the intraperitoneal CR by administrating TS-1 orally and paclitaxel intraperitoneally].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2003, Volume: 30, Issue:11

    Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Drug Administration Sche

2003
[Two resected cases of advanced gastric cancer with peritoneal dissemination after successful treatment with TS-1 plus low-dose CDDP].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2003, Volume: 30, Issue:13

    Topics: Aged; Anorexia; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Dose-Response Relationshi

2003
[A case of type 4 gastric cancer with peritoneal dissemination successfully treated over 2 years by alternate-day administration of TS-1].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2004, Volume: 31, Issue:2

    Topics: Adenocarcinoma; Antimetabolites, Antineoplastic; Carcinoma, Signet Ring Cell; Drug Administration Sc

2004
[A case of gastric cancer with umbilical metastasis that responded to TS-1 with low-dose cis-platinum].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2004, Volume: 31, Issue:2

    Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Signet Ring Cell; Cisplat

2004
[A case of advanced colon cancer with peritoneal dissemination completely responding to TS-1].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2004, Volume: 31, Issue:2

    Topics: Adenocarcinoma; Administration, Oral; Antimetabolites, Antineoplastic; Colectomy; Colonic Neoplasms;

2004
[TS-1 was prescribed for a patient with stomach cancer with peritoneal dissemination who survived for 3 years and 2 months].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2004, Volume: 31, Issue:8

    Topics: Adenocarcinoma; Adult; Antimetabolites, Antineoplastic; Chemotherapy, Adjuvant; Drug Administration

2004
Dihydropyrimidine dehydrogenase inhibitory fluoropyrimidine S-1 may be effective against peritoneal dissemination in gastric cancer.
    Oncology reports, 2004, Volume: 12, Issue:5

    Topics: Administration, Oral; Animals; Antimetabolites, Antineoplastic; Ascites; Dihydrouracil Dehydrogenase

2004
[A case of recurrent gastric cancer with peritoneal dissemination successfully treated with DJ stents against bilateral hydronephrosis and chemotherapy].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2004, Volume: 31, Issue:11

    Topics: Adenocarcinoma; Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Combined M

2004
[A case of a nonresected gastric cancer with peritoneal dissemination maintained on TS-1 and docetaxel combination chemotherapy with good QOL].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2005, Volume: 32, Issue:2

    Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Docetaxel; Drug Administration

2005
[A case of advanced gastric cancer with peritoneal dissemination effectively treated by combined chemotherapy of paclitaxel (TXL) and TS-1].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2005, Volume: 32, Issue:5

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Signet Ring Cell; Drug Administration Sch

2005
[TS-1 treatment for progressive gastric cancer in a patient on chronic dialysis--assessment of dosage regimen by monitoring blood concentrations of therapeutic drugs (TDM)].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2005, Volume: 32, Issue:6

    Topics: Adenocarcinoma; Adult; Antimetabolites, Antineoplastic; Area Under Curve; Drug Administration Schedu

2005
[TS-1 therapy via intestinal catheter used for tube feeding in a patient with gastric cancer after total gastrectomy].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2005, Volume: 32, Issue:7

    Topics: Aged; Antimetabolites, Antineoplastic; Catheterization; Combined Modality Therapy; Drug Administrati

2005
[A case of remnant gastric cancer with multiple bone metastasis and peritoneal dissemination; efficacy of combination therapy of docetaxel and TS-1].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2005, Volume: 32, Issue:7

    Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Combined Modal

2005
[A case of gastric cancer with peritoneal recurrence which developed during adjuvant administration of TS-1 showing complete response by weekly docetaxel regimen].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2005, Volume: 32, Issue:7

    Topics: Adenocarcinoma; Antineoplastic Agents, Phytogenic; Carcinoembryonic Antigen; Chemotherapy, Adjuvant;

2005
[Preoperative combination chemotherapy with TS-1 is effective in a case gastric cancer with peritoneal dissemination].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2005, Volume: 32, Issue:9

    Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Ascites; Cisplatin; Drug Administrat

2005
[Peritoneal dissemination of scirrhous type 4 gastric cancers].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2005, Volume: 32, Issue:10

    Topics: Adenocarcinoma, Scirrhous; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; C

2005
[Treatment strategy for primary gastric cancer with peritoneal dissemination].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2005, Volume: 32, Issue:10

    Topics: Antineoplastic Combined Chemotherapy Protocols; Drug Administration Schedule; Drug Combinations; Flu

2005
[Prediction and treatment of peritoneal dissemination in gastric cancer].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2005, Volume: 32, Issue:10

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Drug Administration Schedule; Drug Combination

2005
[Two cases of advanced gastric cancer, successfully treated with TS-1/CDDP combination chemotherapy--case report].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2005, Volume: 32, Issue:10

    Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Administration Sched

2005
[Effect of intraperitoneal chemotherapy on experimental peritoneal dissemination of gastric cancer].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2005, Volume: 32, Issue:11

    Topics: Animals; Antimetabolites, Antineoplastic; Antineoplastic Agents; Carboplatin; Cisplatin; Docetaxel;

2005
[Safety and efficacy of chemotherapy using TS-1 followed by paclitaxel for advanced or recurrent gastric cancer with peritoneal dissemination].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2005, Volume: 32, Issue:11

    Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic;

2005
[A case of peritoneal dissemination disappeared by CPT-11 + TS-1 combination chemotherapy].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2005, Volume: 32, Issue:11

    Topics: Administration, Oral; Adult; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Ant

2005
[Two cases of advanced gastric cancer with peritoneal dissemination acquired long-term response three years or more by postoperative treatment with oral anticancer drug TS-1].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2006, Volume: 33, Issue:1

    Topics: Adenocarcinoma, Mucinous; Administration, Oral; Aged; Antimetabolites, Antineoplastic; Combined Moda

2006
[Liver metastasis from sigmoid colon cancer with peritoneal dissemination showed a complete response to TS-1].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2006, Volume: 33, Issue:1

    Topics: Adenocarcinoma; Antimetabolites, Antineoplastic; Biomarkers, Tumor; CA-19-9 Antigen; Carcinoembryoni

2006
A synergic inhibitory-effect of combination with selective cyclooxygenase-2 inhibitor and S-1 on the peritoneal metastasis for scirrhous gastric cancer cells.
    Cancer letters, 2006, Dec-08, Volume: 244, Issue:2

    Topics: Adenocarcinoma, Scirrhous; Animals; Antimetabolites, Antineoplastic; Benzenesulfonates; Cyclooxygena

2006
[A case of gastric cancer with peritoneal dissemination who achieved five-year survival by successive treatments with TS-1 alone and in combination with other drugs].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2006, Volume: 33, Issue:2

    Topics: Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Camptothecin;

2006
[Two cases of gastric cancer with peritoneal dissemination that responded to TS-1 without progression or recurrence for over 3 years].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2006, Volume: 33, Issue:2

    Topics: Aged; Antimetabolites, Antineoplastic; Combined Modality Therapy; Drug Administration Schedule; Drug

2006
[A case of nonresected gastric cancer with peritoneal dissemination maintained on TS-1, cisplatin (CDDP) and docetaxel combination chemotherapy with good QOL].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2006, Volume: 33, Issue:2

    Topics: Adenocarcinoma, Mucinous; Antineoplastic Combined Chemotherapy Protocols; Cardia; Cisplatin; Docetax

2006
[A case of recurrent gastric cancer with peritoneal dissemination successfully treated over 1 year 8 months with combined chemotherapy of paclitaxel and TS-1].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2006, Volume: 33, Issue:2

    Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Drug Admi

2006
[Successful bi-weekly paclitaxel treatment of an AFP-producing gastric cancer patient with peritoneal dissemination and multiple liver metastasis].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2006, Volume: 33, Issue:4

    Topics: Aged; alpha-Fetoproteins; Antineoplastic Agents, Phytogenic; Combined Modality Therapy; Drug Adminis

2006
Pharmacokinetics of S-1 in patients with peritoneal dissemination of gastric cancer.
    Oncology reports, 2006, Volume: 16, Issue:2

    Topics: Adult; Aged; Antimetabolites, Antineoplastic; Biological Availability; Drug Combinations; Female; Fl

2006
[A case of long-term survival of gastric cancer with peritoneal metastasis effectively treated by TS-1 and paclitaxel (PTX) combination therapy].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2006, Volume: 33, Issue:7

    Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Constriction, Pathologic; Drug Administra

2006
Efficacy of S-1 for patients with peritoneal metastasis of gastric cancer.
    Chemotherapy, 2006, Volume: 52, Issue:6

    Topics: Adult; Aged; Antimetabolites, Antineoplastic; Biomarkers, Tumor; Dihydrouracil Dehydrogenase (NADP);

2006
[A case of duodenal carcinoma with massive peritoneal carcinomatosis complicating a pulmonary embolism].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2006, Volume: 33, Issue:11

    Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Docetaxel; Drug Combinations; Drug T

2006
[A case of advanced gastric cancer with peritoneal dissemination responding remarkably to TS-1/CDDP combination chemotherapy].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2006, Volume: 33, Issue:13

    Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Administration Sched

2006
[A case of paclitaxel-resistant cancerous ascites secondary to gastric carcinoma responding well to TS-1 therapy].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2006, Volume: 33, Issue:13

    Topics: Aged, 80 and over; Antimetabolites, Antineoplastic; Ascites; Drug Administration Schedule; Drug Comb

2006
[Two cases of primary peritoneal cystadenocarcinoma--diagnosis, treatment, and clinical feature].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2006, Volume: 33, Issue:12

    Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cystadenocarcino

2006
[A case report of advanced gastric cancer with carcinomatous ascites successfully treated by outpatient chemotherapy].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2007, Volume: 34, Issue:1

    Topics: Ambulatory Care; Antineoplastic Combined Chemotherapy Protocols; Ascites; Ascitic Fluid; Cisplatin;

2007
[A case of advanced gastric cancer with peritoneal dissemination effectively treated with fourth-line chemotherapy of S-1 alone].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2007, Volume: 34, Issue:6

    Topics: Adenocarcinoma; Adult; Antimetabolites, Antineoplastic; Drug Administration Schedule; Drug Combinati

2007
[Case of advanced gastric cancer successfully treated with chemotherapy of weekly paclitaxel].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2007, Volume: 34, Issue:7

    Topics: Adenocarcinoma; Aged; Antineoplastic Agents, Phytogenic; Cisplatin; Drug Administration Schedule; Dr

2007
Long-term outcomes of patients with metastatic gastric cancer after initial S-1 monotherapy.
    Journal of gastroenterology, 2007, Volume: 42, Issue:7

    Topics: Adult; Aged; Antimetabolites, Antineoplastic; Disease Progression; Disease-Free Survival; Drug Combi

2007
[Prolonged complete response obtained by single agent S-1 in a case of peritoneal metastasis from gastric remnant cancer].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2007, Volume: 34, Issue:10

    Topics: Antimetabolites, Antineoplastic; Drug Combinations; Gastric Stump; Humans; Male; Middle Aged; Neopla

2007
[Retrospective analysis of treatment for advanced gastric cancer with peritoneal dissemination].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2007, Volume: 34, Issue:11

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined

2007
[A case of advanced gastric cancer with peritoneal dissemination responding to S-1/CDDP neoadjuvant chemotherapy].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2007, Volume: 34, Issue:11

    Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Administration Sched

2007
Intraperitoneal administration of paclitaxel and oral S-1 for a patient with peritoneal dissemination and hydronephrosis due to advanced gastric cancer.
    Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, 2007, Volume: 10, Issue:4

    Topics: Adenocarcinoma; Administration, Oral; Adult; Antineoplastic Agents; Antineoplastic Combined Chemothe

2007
[A case report of curative resection for gastric cancer with peritoneal dissemination successfully treated by combined chemotherapy of S-1 and paclitaxel].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2008, Volume: 35, Issue:5

    Topics: Adenocarcinoma; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic C

2008
[A case of advanced gastric cancer with peritoneal metastasis successfully treated over 19 months with postoperative chemotherapy after non-curative surgery].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2008, Volume: 35, Issue:5

    Topics: Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Ch

2008
[A case of advanced gastric cancer with Schnitzler's metastases effectively treated by the combination of paclitaxel and S-1].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2008, Volume: 35, Issue:5

    Topics: Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Ch

2008
Complete response of highly advanced gastric cancer with peritoneal dissemination after new combined chemotherapy of S-1 and low-dose cisplatin: report of a case.
    Oncology, 2001, Volume: 61, Issue:1

    Topics: Adenocarcinoma; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Cis

2001
Unusual survival for more than 2 years with peritoneal metastases of gastric cancer.
    Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, 2002, Volume: 5, Issue:1

    Topics: Aged; Antimetabolites, Antineoplastic; Drug Administration Schedule; Drug Combinations; Gastrectomy;

2002
[Three cases of recurrent gastric cancer responding to TS-1 therapy following combination therapy with 5-fluorouracil, mitomycin C and cisplatin].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2002, Volume: 29, Issue:5

    Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Administ

2002
[Evaluation of the efficacy of TS-1 for peritoneal dissemination of gastric cancer using a newly-developed animal model].
    Nihon Geka Gakkai zasshi, 2002, Volume: 103, Issue:5

    Topics: Administration, Oral; Animals; Antimetabolites, Antineoplastic; Disease Models, Animal; Drug Combina

2002